Title,Authors,Platform,Cited_url,Cited_count,Year
Missing value estimation methods for DNA microarrays,"O Troyanskaya, M Cantor, G Sherlock, P Brown, T Hastie, R Tibshirani, ...","Bioinformatics 17 (6), 520-525",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3619060742417172543,3028,2001
Diversity of gene expression in adenocarcinoma of the lung,"ME Garber, OG Troyanskaya, K Schluens, S Petersen, Z Thaesler, ...","Proceedings of the National Academy of Sciences 98 (24), 13784-13789","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9247171553168552405,5386434583964661273",1463,2001
Estimation of the warfarin dose with clinical and pharmacogenetic data,International Warfarin Pharmacogenetics Consortium,"New England Journal of Medicine 360 (8), 753-764",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7309176584528797983,1439,2009
Personal omics profiling reveals dynamic molecular and medical phenotypes,"R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ...","Cell 148 (6), 1293-1307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9507974777168246853,998,2012
Pharmacogenomics knowledge for personalized medicine,"M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ...","Clinical Pharmacology & Therapeutics 92 (4), 414-417",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9839285417624814811,997,2012
Principal components analysis to summarize microarray experiments: application to sporulation time series,"S Raychaudhuri, JM Stuart, RB Altman","Biocomputing 2000, 455-466",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16296683544380026708,992,1999
Guidelines for investigating causality of sequence variants in human disease,"DG MacArthur, TA Manolio, DP Dimmock, HL Rehm, J Shendure, ...","Nature 508 (7497), 469",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17862053938042423622,937,2014
The chemical genomic portrait of yeast: uncovering a phenotype for all genes,"ME Hillenmeyer, E Fung, J Wildenhain, SE Pierce, S Hoon, W Lee, ...","Science 320 (5874), 362-365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6086291878632637177,892,2008
Doxorubicin pathways: pharmacodynamics and adverse effects,"CF Thorn, C Oshiro, S Marsh, T Hernandez-Boussard, H McLeod, ...","Pharmacogenetics and genomics 21 (7), 440",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7850226821714328409,711,2011
Clinical assessment incorporating a personal genome,"EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ...","The Lancet 375 (9725), 1525-1535",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13431184763950420692,688,2010
A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae),"OG Troyanskaya, K Dolinski, AB Owen, RB Altman, D Botstein","Proceedings of the National Academy of Sciences 100 (14), 8348-8353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1089383682789994269,668,2003
Method for monitoring and/or modifying web browsing sessions,"RM Felciano, RB Altman","US Patent 6,052,730",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12202813694560366886,632,2000
Clinical Pharmacogenetics Implementation Consortium Guidelines for ,"JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...","Clinical Pharmacology & Therapeutics 90 (4), 625-629",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2675577533195437540,572,2011
Integrating genotype and phenotype information: an overview of the PharmGKB project,"TE Klein, JT Chang, MK Cho, KL Easton, R Fergerson, M Hewett, Z Lin, ...","The pharmacogenomics journal 1 (3), 167",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3111374433342850449,417,2001
Clinical interpretation and implications of whole-genome sequencing,"FE Dewey, ME Grove, C Pan, BA Goldstein, JA Bernstein, H Chaib, ...","Jama 311 (10), 1035-1045",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15642939554663082902,393,2014
Nonparametric methods for identifying differentially expressed genes in microarray data,"OG Troyanskaya, ME Garber, PO Brown, D Botstein, RB Altman","Bioinformatics 18 (11), 1454-1461",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4893956664083757876,380,2002
Data-driven prediction of drug effects and interactions,"NP Tatonetti, PY Patrick, R Daneshjou, RB Altman","Science translational medicine 4 (125), 125ra31-125ra31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7096830056627692788,375,2012
PharmGKB: the pharmacogenetics knowledge base,"M Hewett, DE Oliver, DL Rubin, KL Easton, JM Stuart, RB Altman, ...","Nucleic acids research 30 (1), 163-165",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9649497571352874532,366,2002
A community effort to assess and improve drug sensitivity prediction algorithms,"JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...","Nature biotechnology 32 (12), 1202",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14914623498842388342,361,2014
Investigating hypoxic tumor physiology through gene expression patterns,"NC Denko, LA Fontana, KM Hudson, PD Sutphin, S Raychaudhuri, ...","Oncogene 22 (37), 5907",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10124993762090250046,345,2003
Genomic research and human subject privacy,"Z Lin, AB Owen, RB Altman","Science 305 (5681), 183-183","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15505985859052867022,17600530625945383835",323,2004
SAFA: semi-automated footprinting analysis software for high-throughput quantification of nucleic acid footprinting experiments,"R Das, A Laederach, SM Pearlman, D Herschlag, RB Altman","Rna 11 (3), 344-354",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1417627803837122881,321,2005
Metformin pathways: pharmacokinetics and pharmacodynamics,"L Gong, S Goswami, KM Giacomini, RB Altman, TE Klein","Pharmacogenetics and genomics 22 (11), 820",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11640866382318615147,290,2012
The incidentalome: a threat to genomic medicine,"IS Kohane, DR Masys, RB Altman","Jama 296 (2), 212-215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11969630299731704536,287,2006
Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways,"KJ Kohlhoff, D Shukla, M Lawrenz, GR Bowman, DE Konerding, D Belov, ...","Nature chemistry 6 (1), 15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11349907402343029001,284,2014
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features,"KH Yu, C Zhang, GJ Berry, RB Altman, C Ré, DL Rubin, M Snyder","Nature communications 7, 12474",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9194294294792059630,283,2016
Coarse-grained modeling of large RNA molecules with knowledge-based potentials and structural filters,"MA Jonikas, RJ Radmer, A Laederach, R Das, S Pearlman, D Herschlag, ...","Rna 15 (2), 189-199",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12709466542212335325,274,2009
Creating an online dictionary of abbreviations from MEDLINE,"JT Chang, H Schütze, RB Altman","Journal of the American Medical Informatics Association 9 (6), 612-620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10173970207317592205,272,2002
Associating genes with gene ontology codes using a maximum entropy analysis of biomedical literature,"S Raychaudhuri, JT Chang, PD Sutphin, RB Altman","Genome research 12 (1), 203-214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15264943422846072748,260,2002
Bioinformatics challenges for personalized medicine,"GH Fernald, E Capriotti, R Daneshjou, KJ Karczewski, RB Altman","Bioinformatics 27 (13), 1741-1748",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9912314304040893293,257,2011
Pharmacogenomics: challenges and opportunities,"DM Roden, RB Altman, NL Benowitz, DA Flockhart, KM Giacomini, ...","Annals of internal medicine 145 (10), 749",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17051888254589630345,256,2006
The pharmacogenetics research network: from SNP discovery to clinical drug response,"KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ...","Clinical Pharmacology & Therapeutics 81 (3), 328-345",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13054207835808888033,255,2007
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity,"PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ...","Nature medicine 22 (5), 547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3467606196906531828,253,2016
Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery,"I Yeh, T Hanekamp, S Tsoka, PD Karp, RB Altman","Genome research 14 (5), 917-924",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7599234646050524602,247,2004
"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","LM Hodges, SM Markova, LW Chinn, JM Gow, DL Kroetz, TE Klein, ...","Pharmacogenetics and genomics 21 (3), 152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11243722872821920806,239,2011
Challenges in the clinical application of whole-genome sequencing,"KE Ormond, MT Wheeler, L Hudgins, TE Klein, AJ Butte, RB Altman, ...","The Lancet 375 (9727), 1749-1751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11049444656011428567,233,2010
Web-scale pharmacovigilance: listening to signals from the crowd,"RW White, NP Tatonetti, NH Shah, RB Altman, E Horvitz","Journal of the American Medical Informatics Association 20 (3), 404-408",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11093704460083137545,214,2013
Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms,"PK Sorger, SRB Allerheiligen, DR Abernethy, RB Altman, KLR Brouwer, ...",An NIH white paper by the QSP workshop group 48,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2592158621809827592,198,2011
Modelling biological processes using workflow and petri net models,"M Peleg, I Yeh, RB Altman","Bioinformatics 18 (6), 825-837","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10708853236307234357,5169515245289847733",198,2002
Basic microarray analysis: grouping and feature reduction,"S Raychaudhuri, PD Sutphin, JT Chang, RB Altman","TRENDS in Biotechnology 19 (5), 189-193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12902461572896100853,197,2001
Detecting drug interactions from adverse‐event reports: interaction between paroxetine and pravastatin increases blood glucose levels,"NP Tatonetti, JC Denny, SN Murphy, GH Fernald, G Krishnan, V Castro, ...","Clinical Pharmacology & Therapeutics 90 (1), 133-142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15159149220015958746,187,2011
Whole-genome expression analysis: challenges beyond clustering,"RB Altman, S Raychaudhuri","Current opinion in structural biology 11 (3), 340-347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5796956045385870321,187,2001
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study,"MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ...","The Lancet 382 (9894), 790-796",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16345370499527645621,186,2013
Eukaryotic regulatory element conservation analysis and identification using comparative genomics,"Y Liu, XS Liu, L Wei, RB Altman, S Batzoglou","Genome Research 14 (3), 451-458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6763848893965500182,172,2004
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource,"EM McDonagh, M Whirl-Carrillo, Y Garten, RB Altman, TE Klein","Biomarkers in medicine 5 (6), 795-806",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=512031967895137708,167,2011
Cytochrome P450 2C9-CYP2C9,"D Van Booven, S Marsh, H McLeod, MW Carrillo, K Sangkuhl, TE Klein, ...","Pharmacogenetics and genomics 20 (4), 277",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13707079487510317373,161,2010
"Knowledge acquisition, consistency checking and concurrency control for Gene Ontology (GO)","I Yeh, PD Karp, NF Noy, RB Altman","Bioinformatics 19 (2), 241-248",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18368457515812283774,158,2003
Characterizing the microenvironment surrounding protein sites,"SC Bagley, RB Altman","Protein Science 4 (4), 622-635",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9169141414279906920,154,1995
Clopidogrel pathway,"K Sangkuhl, TE Klein, RB Altman","Pharmacogenetics and genomics 20 (7), 463",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8486883980251761172,153,2010
 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations,"MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ...","Clinical Pharmacology & Therapeutics 95 (2), 216-227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16747529762601972378,151,2014
Using Petri net tools to study properties and dynamics of biological systems,"M Peleg, D Rubin, RB Altman","Journal of the American Medical Informatics Association 12 (2), 181-199",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3472187879575898497,150,2005
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports,"NP Tatonetti, GH Fernald, RB Altman","Journal of the American Medical Informatics Association 19 (1), 79-85",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12473667365055409841,144,2011
A community computational challenge to predict the activity of pairs of compounds,"M Bansal, J Yang, C Karan, MP Menden, JC Costello, H Tang, G Xiao, ...","Nature biotechnology 32 (12), 1213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13917892246742977255,141,2014
PharmGKB summary: cyclosporine and tacrolimus pathways,"JM Barbarino, CE Staatz, R Venkataramanan, TE Klein, RB Altman","Pharmacogenetics and genomics 23 (10), 563",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17339915619814677782,141,2013
Finding haplotype tagging SNPs by use of principal components analysis,"Z Lin, RB Altman","The American Journal of Human Genetics 75 (5), 850-861",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3677055818304559873,141,2004
Challenges for biomedical informatics and pharmacogenomics,"RB Altman, TE Klein","Annual review of pharmacology and toxicology 42 (1), 113-133",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10722563263308662891,141,2002
GAPSCORE: finding gene and protein names one word at a time,"JT Chang, H Schütze, RB Altman","Bioinformatics 20 (2), 216-225",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15514114291153268405,136,2004
Proceedings: Second international conference on intelligent systems for molecular biology,"R Altman, D Brutlag, P Karp, R Lathrop, D Searls","Stanford Univ., CA (United States)",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3519582801382006791,135,1994
Sequence-specific proton NMR assignments and secondary structure in solution of Escherichia coli trp repressor,"CH Arrowsmith, R Pachter, RB Altman, SB Iyer, O Jardetzky","Biochemistry 29 (27), 6332-6341",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15017952358867841307,134,1990
RNAML: a standard syntax for exchanging RNA information,"A Waugh, P Gendron, R Altman, JW Brown, D Case, D Gautheret, ...","Rna 8 (6), 707-717",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5347604471669248908,132,2002
Valproic acid pathway: pharmacokinetics and pharmacodynamics,"Y Ghodke-Puranik, CF Thorn, JK Lamba, JS Leeder, W Song, ...","Pharmacogenetics and genomics 23 (4), 236",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11971681591004374327,131,2013
PharmGKB: the pharmacogenomics knowledge base,"CF Thorn, TE Klein, RB Altman","Pharmacogenomics, 311-320",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12025120831002006328,128,2013
Emerging scientific applications in data mining,"J Han, RB Altman, V Kumar, H Mannila, D Pregibon","Communications of the ACM 45 (8), 54-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7011453830085559805,128,2002
Phased whole-genome genetic risk in a family quartet using a major allele reference sequence,"FE Dewey, R Chen, SP Cordero, KE Ormond, C Caleshu, KJ Karczewski, ...","PLoS genetics 7 (9), e1002280",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9935976593765779743,126,2011
Health-information altruists–a potentially critical resource,"IS Kohane, RB Altman","N Engl J Med 353 (19), 2074-2077",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8030728179434636164,124,2005
Collective judgment predicts disease-associated single nucleotide variants,"E Capriotti, RB Altman, Y Bromberg","BMC genomics 14 (3), S2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9117291935395936548,120,2013
RiboWeb: An ontology-based system for collaborative molecular biology,"RB Altman, M Buda, XJ Chai, MW Carillo, RO Chen, NF Abernethy","IEEE Intelligent Systems and Their Applications 14 (5), 68-76",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1050639523496216108,119,1999
Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text,"Y Garten, RB Altman","BMC bioinformatics 10 (2), S6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9845411937597775886,117,2009
Pharmacogenomics and bioinformatics: PharmGKB,"CF Thorn, TE Klein, RB Altman","Pharmacogenomics 11 (4), 501-505",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9024054036021431855,115,2010
Text mining for biology-the way forward: opinions from leading scientists,"RB Altman, CM Bergman, J Blake, C Blaschke, A Cohen, F Gannon, ...","Genome biology 9 (2), S7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8439255733509506305,115,2008
Using text to build semantic networks for pharmacogenomics,"A Coulet, NH Shah, Y Garten, M Musen, RB Altman","Journal of biomedical informatics 43 (6), 1009-1019",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2755251299511271266,114,2010
"PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19","SA Scott, K Sangkuhl, AR Shuldiner, JS Hulot, CF Thorn, RB Altman, ...","Pharmacogenetics and genomics 22 (2), 159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16892986163487289320,113,2012
Average core structures and variability measures for protein families: application to the immunoglobulins,"M Gerstein, RB Altman","Journal of molecular biology 251 (1), 161-175",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8962892838946582486,113,1995
A curriculum for bioinformatics: the time is ripe.,RB Altman,"Bioinformatics (Oxford, England) 14 (7), 549-550",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2013469684241891130,112,1998
Discovery and explanation of drug-drug interactions via text mining,"B Percha, Y Garten, RB Altman","Biocomputing 2012, 410-421",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10736863471140053759,109,2012
High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis,"S Mitra, IV Shcherbakova, RB Altman, M Brenowitz, A Laederach","Nucleic acids research 36 (11), e63-e63",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15732137717436924239,107,2008
WebFEATURE: an interactive web tool for identifying and visualizing functional sites on macromolecular structures,"MP Liang, DR Banatao, TE Klein, DL Brutlag, RB Altman","Nucleic acids research 31 (13), 3324-3327",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12250864631022201646,107,2003
Using text analysis to identify functionally coherent gene groups,"S Raychaudhuri, H Schütze, RB Altman","Genome Research 12 (10), 1582-1590",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11806957862961375806,107,2002
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype,RB Altman,"Nature genetics 39 (4), 426",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5479485509461898517,105,2007
Time to organize the bioinformatics resourceome,"N Cannata, E Merelli, RB Altman","PLoS Computational Biology 1 (7), e76",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8022128026136010058,105,2005
WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation,"E Capriotti, R Calabrese, P Fariselli, PL Martelli, RB Altman, R Casadio","BMC genomics 14 (3), S6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13091628119866133317,103,2013
Independent component analysis: mining microarray data for fundamental human gene expression modules,"JM Engreitz, BJ Daigle Jr, JJ Marshall, RB Altman","Journal of biomedical informatics 43 (6), 932-944",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2422908136911507787,102,2010
The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge,"T Hernandez-Boussard, M Whirl-Carrillo, JM Hebert, L Gong, R Owen, ...","Nucleic acids research 36 (suppl_1), D913-D918",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9073440442353791762,100,2007
The RNA Ontology Consortium: an open invitation to the RNA community,"NB Leontis, RB Altman, HM Berman, SE Brenner, JW Brown, DR Engelke, ...","Rna 12 (4), 533-541",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7469247544793200876,97,2006
Robust recognition of zinc binding sites in proteins,"JC Ebert, RB Altman","Protein Science 17 (1), 54-65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12670521036411567990,95,2008
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses,"LL Mazaleuskaya, K Sangkuhl, CF Thorn, GA FitzGerald, RB Altman, ...","Pharmacogenetics and genomics 25 (8), 416",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14775033259771602260,94,2015
Informatics confronts drug–drug interactions,"B Percha, RB Altman","Trends in pharmacological sciences 34 (3), 178-184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6854476768714156748,94,2013
PharmGKB,"CF Thorn, TE Klein, RB Altman","Pharmacogenomics, 179-191","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5653119670528360579,1417106950805518387",94,2005
Reconstruction of the mouse otocyst and early neuroblast lineage at single-cell resolution,"R Durruthy-Durruthy, A Gottlieb, BH Hartman, J Waldhaus, RD Laske, ...","Cell 157 (4), 964-978",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1768267536995370622,92,2014
Structural inference of native and partially folded RNA by high-throughput contact mapping,"R Das, M Kudaravalli, M Jonikas, A Laederach, R Fong, JP Schwans, ...","Proceedings of the National Academy of Sciences 105 (11), 4144-4149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16164026053586182411,92,2008
The solution structures of ,"C ARROWSMITH, R PACHTER, R ALTMAN, O JARDETZKY","European Journal of Biochemistry 202 (1), 53-66",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17802388662915956047,92,1991
Machine learning in chemoinformatics and drug discovery,"YC Lo, SE Rensi, W Torng, RB Altman","Drug discovery today 23 (8), 1538-1546",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11964839206980330302,90,2018
Implementing personalized medicine: development of a cost‐effective customized pharmacogenetics genotyping array,"JA Johnson, BM Burkley, TY Langaee, MJ Clare‐Salzler, TE Klein, ...","Clinical Pharmacology & Therapeutics 92 (4), 437-439",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16527799910622877417,87,2012
PROTEAN: Deriving protein structure from constraints.,"B Hayes-Roth, BG Buchanan, O Lichtarge, M Hewett, RB Altman, ...",American Association for Artificial Intelligence,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8871143678012138236,87,1986
PharmGKB summary: fluoropyrimidine pathways,"CF Thorn, S Marsh, MW Carrillo, HL McLeod, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (4), 237",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10325360934057890548,86,2011
Codeine and morphine pathway,"CF Thorn, TE Klein, RB Altman","Pharmacogenetics and genomics 19 (7), 556-558",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9181007655341900770,86,2009
Recognizing protein binding sites using statistical descriptions of their 3D environments.,"L Wei, RB Altman","Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 497-508",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9359256542248476598,85,1998
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response,"JM Biernacka, K Sangkuhl, G Jenkins, RM Whaley, P Barman, A Batzler, ...","Translational psychiatry 5 (4), e553",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5618974312403678776,84,2015
Improving the prediction of disease-related variants using protein three-dimensional structure,"E Capriotti, RB Altman","BMC bioinformatics 12 (4), S3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5829019648803205522,84,2011
"A survey of patient access to electronic mail: attitudes, barriers, and opportunities.","DB Fridsma, P Ford, R Altman","Proceedings of the annual symposium on computer application in medical care, 15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11790437185892312622,83,1994
PharmGKB summary: very important pharmacogene information for CYP3A5,"J Lamba, JM Hebert, EG Schuetz, TE Klein, RB Altman","Pharmacogenetics and genomics 22 (7), 555",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15699057887131628824,82,2012
PharmGKB summary: methotrexate pathway,"TS Mikkelsen, CF Thorn, JJ Yang, CM Ulrich, D French, G Zaza, ...","Pharmacogenetics and genomics 21 (10), 679",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5823053343349931879,82,2011
Pharmacogenomics:“noninferiority” is sufficient for initial implementation,RB Altman,"Clinical Pharmacology & Therapeutics 89 (3), 348-350",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2378255767187469849,82,2011
PharmGKB: understanding the effects of individual genetic variants,"K Sangkuhl, DS Berlin, RB Altman, TE Klein","Drug metabolism reviews 40 (4), 539-551",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10491987892356341541,82,2008
VKORC1 pharmacogenomics summary,"RP Owen, L Gong, H Sagreiya, TE Klein, RB Altman","Pharmacogenetics and genomics 20 (10), 642",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3818153298568652986,81,2010
Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9,"H Sagrieya, C Berube, A Wen, R Ramakrishnan, A Mir, A Hamilton, ...","Pharmacogenetics and genomics 20 (7), 407","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2466352315505410556,15496012995268892996",81,2010
Cytochrome P450 2D6,"RP Owen, K Sangkuhl, TE Klein, RB Altman","Pharmacogenetics and genomics 19 (7), 559",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16222970595338281722,80,2009
The computational analysis of scientific literature to define and recognize gene expression clusters,"S Raychaudhuri, JT Chang, F Imam, RB Altman","Nucleic Acids Research 31 (15), 4553-4560",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13845836989567995062,80,2003
Choosing SNPs using feature selection,"TM Phuong, Z Lin, RB Altman","2005 IEEE Computational Systems Bioinformatics Conference (CSB'05), 301-309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=327134036077132752,79,2005
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism,"MV Relling, RB Altman, MP Goetz, WE Evans","The lancet oncology 11 (6), 507-509","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4900273940821160050,4902271537466588578",78,2010
Recent progress in automatically extracting information from the pharmacogenomic literature,"Y Garten, A Coulet, RB Altman","Pharmacogenomics 11 (10), 1467-1489",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7075303865826436321,77,2010
The ethics of characterizing difference: guiding principles on using racial categories in human genetics,"SSJ Lee, J Mountain, B Koenig, R Altman, M Brown, A Camarillo, ...","Genome biology 9 (7), 404",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11755534955656383012,77,2008
Predicting allosteric communication in myosin via a pathway of conserved residues,"S Tang, JC Liao, AR Dunn, RB Altman, JA Spudich, JP Schmidt","Journal of molecular biology 373 (5), 1361-1373",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9244114735179672092,75,2007
Platelet aggregation pathway,"K Sangkuhl, AR Shuldiner, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (8), 516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4628266291159563535,73,2011
Predicting drug side-effects by chemical systems biology,"NP Tatonetti, T Liu, RB Altman","Genome biology 10 (9), 238",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5802409056214946277,73,2009
Generating genome‐scale candidate gene lists for pharmacogenomics,"NT Hansen, S Brunak, RB Altman","Clinical Pharmacology & Therapeutics 86 (2), 183-189",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6457537185083438850,73,2009
A call for the creation of personalized medicine databases,"D Gurwitz, JE Lunshof, RB Altman","Nature Reviews Drug Discovery 5 (1), 23",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18405776620078443779,73,2006
Training the next generation of informaticians: The impact of “BISTI” and bioinformatics—A report from the American College of Medical Informatics,"CP Friedman, RB Altman, IS Kohane, KA McCormick, PL Miller, JG Ozbolt, ...","Journal of the American Medical Informatics Association 11 (3), 167-172",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13606338452367975690,73,2004
Thiopurine pathway,"G Zaza, M Cheok, N Krynetskaia, C Thorn, G Stocco, JM Hebert, ...","Pharmacogenetics and genomics 20 (9), 573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=634392672396075835,72,2010
Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML,"DL Rubin, M Hewett, DE Oliver, TE Klein, RB Altman","Biocomputing 2002, 88-99",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9188841566877268378,72,2001
A literature-based method for assessing the functional coherence of a gene group,"S Raychaudhuri, RB Altman","Bioinformatics 19 (3), 396-401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11914613086604560044,71,2003
Celecoxib pathways: pharmacokinetics and pharmacodynamics,"L Gong, CF Thorn, MM Bertagnolli, T Grosser, RB Altman, TE Klein","Pharmacogenetics and genomics 22 (4), 310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2685126630429838347,70,2012
Very important pharmacogene summary ADRB2,"AA Litonjua, L Gong, QL Duan, J Shin, MJ Moore, ST Weiss, JA Johnson, ...","Pharmacogenetics and genomics 20 (1), 64",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7670533835240373821,70,2010
MScanner: a classifier for retrieving Medline citations,"GL Poulter, DL Rubin, RB Altman, C Seoighe","BMC bioinformatics 9 (1), 108",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1299317323052808511,70,2008
"Distinct contribution of electrostatics, initial conformational ensemble, and macromolecular stability in RNA folding","A Laederach, I Shcherbakova, MA Jonikas, RB Altman, M Brenowitz","Proceedings of the National Academy of Sciences 104 (17), 7045-7050",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17530270663756443345,70,2007
Including biological literature improves homology search,"JT Chang, S Raychaudhuri, RB Altman","Biocomputing 2001, 374-383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16227467504054196177,70,2000
The Simbios National Center: systems biology in motion,"JP Schmidt, SL Delp, MA Sherman, CA Taylor, VS Pande, RB Altman","Proceedings of the IEEE 96 (8), 1266-1280",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6873718681212378606,69,2008
Semiautomated and rapid quantification of nucleic acid footprinting and structure mapping experiments,"A Laederach, R Das, Q Vicens, SM Pearlman, M Brenowitz, D Herschlag, ...","Nature protocols 3 (9), 1395",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9853366882874289897,68,2008
Bioinformatics and variability in drug response: a protein structural perspective,"JL Lahti, GW Tang, E Capriotti, T Liu, RB Altman","Journal of The Royal Society Interface 9 (72), 1409-1437",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4511608815827265712,67,2012
Extracting and characterizing gene–drug relationships from the literature,"JT Chang, RB Altman","Pharmacogenetics and Genomics 14 (9), 577-586",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9983670871864787972,66,2004
A systematic comparison of three structure determination methods from NMR data: dependence upon quality and quantity of data,"Y Liu, D Zhao, R Altman, O Jardetzky","Journal of Biomolecular NMR 2 (4), 373-388",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17760719975534603310,66,1992
Large-scale extraction of gene interactions from full-text literature using DeepDive,"EK Mallory, C Zhang, C Ré, RB Altman","Bioinformatics 32 (1), 106-113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9396498102283528879,65,2015
Impact of the ,"E Danese, M Montagnana, JA Johnson, AE Rettie, CF Zambon, SA Lubitz, ...","Clinical Pharmacology & Therapeutics 92 (6), 746-756",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4355605805408278817,65,2012
Turning limited experimental information into 3D models of RNA,"SC Flores, RB Altman","Rna 16 (9), 1769-1778",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2040932816338138830,65,2010
Bioinformatics in support of molecular medicine.,RB Altman,"Proceedings of the AMIA Symposium, 53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9563773041516513742,64,1998
The interactions between clinical informatics and bioinformatics: a case study,RB Altman,"Journal of the American Medical Informatics Association 7 (5), 439-443",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2701454289041930561,63,2000
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2,"EM McDonagh, S Boukouvala, E Aklillu, DW Hein, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (8), 409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3415004935360992037,61,2014
PharmGKB summary: very important pharmacogene information for UGT1A1,"JM Barbarino, CE Haidar, TE Klein, RB Altman","Pharmacogenetics and genomics 24 (3), 177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8501637691990430381,61,2014
Informatics in the care of patients: ten notable challenges.,RB Altman,"Western Journal of Medicine 166 (2), 118",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15221730790518018917,61,1997
[11] Heuristic refinement method for determination of solution structure of proteins from nuclear magnetic resonance data,"RB Altman, O Jardetzky","Methods in Enzymology 177, 218-246","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18280840919436592506,17380939010408472278",61,1989
Biomedical term mapping databases,"JD Wren, JT Chang, J Pustejovsky, E Adar, HR Garner, RB Altman","Nucleic acids research 33 (suppl_1), D289-D293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17334780469269280306,60,2005
Large scale study of protein domain distribution in the context of alternative splicing,"S Liu, RB Altman","Nucleic acids research 31 (16), 4828-4835",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5901368864657086358,60,2003
RIBOWEB: linking structural computations to a knowledge base of published experimental data.,"RO Chen, RM Felciano, RB Altman","Ismb, 84-87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14879776729919693236,59,1997
Determining the genomic locations of repetitive DNA sequences with a whole-genome microarray: IS6110 in Mycobacterium tuberculosis,"M Kivi, X Liu, S Raychaudhuri, RB Altman, PM Small","Journal of clinical microbiology 40 (6), 2192-2198",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17129205869947754835,58,2002
Using binning to maintain confidentiality of medical data.,"Z Lin, M Hewett, RB Altman","Proceedings of the AMIA Symposium, 454",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11712615936028359678,58,2002
Computational methods for defining the allowed conformational space of 16S rRNA based on chemical footprinting data.,"DL Fink, RO Chen, HF Noller, RB Altman","Rna 2 (9), 851-866",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14823210801122145869,58,1996
A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge,"DL Rubin, CF Thorn, TE Klein, RB Altman","Journal of the American Medical Informatics Association 12 (2), 121-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10825313632522782310,57,2005
Are predicted structures good enough to preserve functional sites?,"L Wei, ES Huang, RB Altman","Structure 7 (6), 643-650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11319531974406476142,57,1999
Environmental and state-level regulatory factors affect the incidence of autism and intellectual disability,"A Rzhetsky, SC Bagley, K Wang, CS Lyttle, EH Cook Jr, RB Altman, ...","PLoS computational biology 10 (3), e1003518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8347551111171616264,55,2014
Using multiple microenvironments to find similar ligand-binding sites: application to kinase inhibitor binding,"T Liu, RB Altman","PLoS computational biology 7 (12), e1002326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13146254035145290756,54,2011
A new disease-specific machine learning approach for the prediction of cancer-causing missense variants,"E Capriotti, RB Altman","Genomics 98 (4), 310-317",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14165677373020470321,54,2011
Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans,"R Daneshjou, ER Gamazon, B Burkley, LH Cavallari, JA Johnson, ...","Blood 124 (14), 2298-2305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8676239723301517394,53,2014
Pharmacogenomics,"KJ Karczewski, R Daneshjou, RB Altman","PLoS computational biology 8 (12), e1002817",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6775305399626899804,53,2012
PharmGKB summary: caffeine pathway,"CF Thorn, E Aklillu, EM McDonagh, TE Klein, RB Altman","Pharmacogenetics and genomics 22 (5), 389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13842649411890888340,53,2012
Fast flexible modeling of RNA structure using internal coordinates,"SC Flores, M Sherman, CM Bruns, P Eastman, RB Altman",IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB) 8 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15495735311755832842,53,2011
Content-based microarray search using differential expression profiles,"JM Engreitz, AA Morgan, JT Dudley, R Chen, R Thathoo, RB Altman, ...","BMC bioinformatics 11 (1), 603",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9199962686618469040,53,2010
PharmGKB very important pharmacogene: SLCO1B1,"C Oshiro, L Mangravite, T Klein, R Altman","Pharmacogenetics and genomics 20 (3), 211",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14565493397249332456,53,2010
Microenvironment analysis and identification of magnesium binding sites in RNA,"DR Banatao, RB Altman, TE Klein","Nucleic acids research 31 (15), 4450-4460",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5568893306971147973,52,2003
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: outcomes and metrics of pharmacogenetic implementations across diverse healthcare systems,"JA Luzum, RE Pakyz, AR Elsey, CE Haidar, JF Peterson, M Whirl‐Carrillo, ...","Clinical Pharmacology & Therapeutics 102 (3), 502-510",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3405150797109281490,51,2017
MutDB: annotating human variation with functionally relevant data,"SD Mooney, RB Altman","Bioinformatics 19 (14), 1858-1860",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7902693490463842800,51,2003
PharmGKB summary: tramadol pathway,"L Gong, UM Stamer, MV Tzvetkov, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (7), 374",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5910941669549667869,50,2014
"PharmGKB summary: tamoxifen pathway, pharmacokinetics","DJ Klein, CF Thorn, Z Desta, DA Flockhart, RB Altman, TE Klein","Pharmacogenetics and genomics 23 (11), 643",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=871142625121414595,50,2013
Local kinetic measures of macromolecular structure reveal partitioning among multiple parallel pathways from the earliest steps in the folding of a large RNA molecule,"A Laederach, I Shcherbakova, MP Liang, M Brenowitz, RB Altman","Journal of molecular biology 358 (4), 1179-1190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12930452060700714044,50,2006
Building successful biological databases,RB Altman,"Briefings in bioinformatics 5 (1), 4-5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2692057689901048664,50,2004
Knowledge-based instantiation of full atomic detail into coarse-grain RNA 3D structural models,"MA Jonikas, RJ Radmer, RB Altman","Bioinformatics 25 (24), 3259-3266",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13046065452576688433,49,2009
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base,"TE Klein, RB Altman","The pharmacogenomics journal 4 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6577507827541329993,49,2004
Human germline CRISPR-Cas modification: toward a regulatory framework,"NH Evitt, S Mascharak, RB Altman","The American journal of bioethics 15 (12), 25-29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=735544806464468851,48,2015
Databases in the area of pharmacogenetics,"SC Sim, RB Altman, M Ingelman‐Sundberg","Human mutation 32 (5), 526-531",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5299666340110826723,48,2011
Ethics of artificial intelligence,"S Russell, S Hauert, R Altman, M Veloso","Nature 521 (7553), 415-416",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16884812100154130194,47,2015
PharmGKB summary: ibuprofen pathways,"LL Mazaleuskaya, KN Theken, L Gong, CF Thorn, GA FitzGerald, ...","Pharmacogenetics and genomics 25 (2), 96",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6481350823415356703,47,2015
A method for inferring medical diagnoses from patient similarities,"A Gottlieb, GY Stein, E Ruppin, RB Altman, R Sharan","BMC medicine 11 (1), 194",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3466800367369991019,47,2013
Predicting RNA structure by multiple template homology modeling,"SC Flores, Y Wan, R Russell, RB Altman","Biocomputing 2010, 216-227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11189206284179222323,47,2010
Improving structure-based function prediction using molecular dynamics,"DS Glazer, RJ Radmer, RB Altman","Structure 17 (7), 919-929",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9460941722602261933,47,2009
Identifying phenotypic signatures of neuropsychiatric disorders from electronic medical records,"S Lyalina, B Percha, P LePendu, SV Iyer, RB Altman, NH Shah","Journal of the American Medical Informatics Association 20 (e2), e297-e305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14421633296636055657,46,2013
Translational bioinformatics: linking the molecular world to the clinical world,RB Altman,"Clinical Pharmacology & Therapeutics 91 (6), 994-1000",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13719304832876736300,46,2012
Cooperative transcription factor associations discovered using regulatory variation,"KJ Karczewski, NP Tatonetti, SG Landt, X Yang, T Slifer, RB Altman, ...","Proceedings of the National Academy of Sciences 108 (32), 13353-13358",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5344251265297694950,46,2011
"The FEATURE framework for protein function annotation: modeling new functions, improving performance, and extending to novel applications","I Halperin, DS Glazer, S Wu, RB Altman","BMC genomics 9 (2), S2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5510551214986106449,46,2008
"Recognizing complex, asymmetric functional sites in protein structures using a Bayesian scoring function","L Wei, RB Altman","Journal of bioinformatics and computational biology 1 (01), 119-138",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15876544892783106494,46,2003
Assessment of the radiation effects of cardiac CT angiography using protein and genetic biomarkers,"PK Nguyen, WH Lee, YF Li, WX Hong, S Hu, C Chan, G Liang, I Nguyen, ...","JACC: Cardiovascular Imaging 8 (8), 873-884",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14521576303904619331,45,2015
PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single‐drug pharmacogenetics,"RP Owen, RB Altman, TE Klein","Human mutation 29 (4), 456-460",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1953802220661298131,45,2008
Pharmacogenomics‐based point‐of‐care clinical decision support significantly alters drug prescribing,"PH O'Donnell, N Wadhwa, K Danahey, BA Borden, SM Lee, JP Hall, ...","Clinical Pharmacology & Therapeutics 102 (5), 859-869",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12740295848678880876,44,2017
Method And System For Extraction And Normalization Of Relationships Via Ontology Induction,"A Coulet, NH Shah, Y Garten, M Musen, RB Altman","US Patent App. 13/481,808","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5039256022312926815,10328483102728907577",44,2013
PharmGKB summary: very important pharmacogene information for CYP2B6,"CF Thorn, JK Lamba, V Lamba, TE Klein, RB Altman","Pharmacogenetics and genomics 20 (8), 520",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1317652178928099770,44,2010
Very important pharmacogene summary: thiopurine S-methyltransferase,"L Wang, L Pelleymounter, R Weinshilboum, JA Johnson, JM Hebert, ...","Pharmacogenetics and genomics 20 (6), 401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8938630317744875174,44,2010
Efficient algorithms to explore conformation spaces of flexible protein loops,"P Yao, A Dhanik, N Marz, R Propper, C Kou, G Liu, H Van Den Bedem, ...","IEEE/ACM Transactions on Computational Biology and Bioinformatics 5 (4), 534-545",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=895609050853676682,44,2008
Challenges for intelligent systems in biology,RB Altman,"IEEE Intelligent Systems 16 (6), 14-18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1880883423366430962,44,2001
LPFC: an Internet library of protein family core structures,"R Schmidt, RB Altman, M Gerstein","Protein Science 6 (1), 246-248",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13433286362867316313,44,1997
Improving data and knowledge management to better integrate health care and research,"M Cases, LI Furlong, J Albanell, RB Altman, R Bellazzi, S Boyer, A Brand, ...","Journal of internal medicine 274 (4), 321-328",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10962759323631449936,43,2013
PharmGKB summary: very important pharmacogene information for CYP1A2,"CF Thorn, E Aklillu, TE Klein, RB Altman","Pharmacogenetics and genomics 22 (1), 73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5513311453441434694,43,2012
PharmGKB summary: carbamazepine pathway,"CF Thorn, SG Leckband, J Kelsoe, JS Leeder, DJ Müller, TE Klein, ...","Pharmacogenetics and genomics 21 (12), 906",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10778590267439468004,43,2011
Selective serotonin reuptake inhibitors (SSRI) pathway,"K Sangkuhl, T Klein, R Altman","Pharmacogenetics and genomics 19 (11), 907",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2977347540157962293,43,2009
Ontology development for a pharmacogenetics knowledge base,"DE Oliver, DL Rubin, JM Stuart, M Hewett, TE Klein, RB Altman","Biocomputing 2002, 65-76",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8190280280210762152,43,2001
Using the radial distributions of physical features to compare amino acid environments and align amino acid sequences,"L Wei, RB Altman, JT Chang","Pac Symp Biocomput 5, 465-476",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13843933132357709740,43,1997
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes,"ER Behr, MD Ritchie, T Tanaka, S Kääb, DC Crawford, P Nicoletti, ...","PloS one 8 (11), e78511",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=397546121055470643,42,2013
[28] Computational modeling of structural experimental data,"MA Bada, RB Altman","Academic Press 317, 470-491",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=307867030232050178,42,2000
New strategies for the determination of macromolecular structure in solution,"RB ALTMAN, O JARDETZKY","The Journal of Biochemistry 100 (6), 1403-1423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11515452394553663943,42,1986
Integration and publication of heterogeneous text-mined relationships on the Semantic Web,"A Coulet, Y Garten, M Dumontier, RB Altman, MA Musen, NH Shah","Journal of biomedical semantics 2 (2), S10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3429746624963191535,41,2011
Bisphosphonates pathway,"L Gong, RB Altman, TE Klein","Pharmacogenetics and genomics 21 (1), 50",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5046194897145565256,41,2011
Taxane pathway,"C Oshiro, S Marsh, H McLeod, M Carrillo, T Klein, R Altman","Pharmacogenetics and genomics 19 (12), 979",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5041867725450791903,41,2009
PharmGKB: an integrated resource of pharmacogenomic data and knowledge,"L Gong, RP Owen, W Gor, RB Altman, TE Klein","Current protocols in bioinformatics 23 (1), 14.7. 1-14.7. 17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8054435860218043947,41,2008
Drug Targets for Plasmodium falciparum: a post-genomic review/survey.,"I Yeh, RB Altman","Mini reviews in medicinal chemistry 6 (2), 177-202",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17842510973071240282,41,2006
Neurotoxicity of generic anesthesia agents in infants and children: an orphan research question in search of a sponsor,"BM Psaty, R Platt, RB Altman","Jama 313 (15), 1515-1516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17188555574524307347,40,2015
Platinum pathway,"S Marsh, H McLeod, E Dolan, SJ Shukla, CA Rabik, L Gong, ...","Pharmacogenetics and genomics 19 (7), 563",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8814981906130370578,40,2009
Etoposide pathway,"J Yang, A Bogni, EG Schuetz, M Ratain, ME Dolan, H McLeod, L Gong, ...","Pharmacogenetics and genomics 19 (7), 552-553",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14668113174737508640,39,2009
Automated construction of structural motifs for predicting functional sites on protein structures,"MP Liang, DL Brutlag, RB Altman","Biocomputing 2003, 204-215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6098690975220009152,39,2002
3D deep convolutional neural networks for amino acid environment similarity analysis,"W Torng, RB Altman","BMC bioinformatics 18 (1), 302",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9851670782314609223,38,2017
Structural characterization of proteins using residue environments,"SD Mooney, MHP Liang, R DeConde, RB Altman","Proteins: Structure, Function, and Bioinformatics 61 (4), 741-747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9719940189533986004,38,2005
Tools for loading MEDLINE into a local relational database,"DE Oliver, G Bhalotia, AS Schwartz, RB Altman, MA Hearst","BMC bioinformatics 5 (1), 146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7466799980752427694,38,2004
Heuristic refinement method for the derivation of protein solution structures: validation on cytochrome b562,"JF Brinkley, RB Altman, BS Duncan, BG Buchanan, O Jardetzky","Journal of chemical information and computer sciences 28 (4), 194-210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6849181432399798561,38,1988
Very important pharmacogene summary for VDR,"AH Poon, L Gong, C Brasch-Andersen, AA Litonjua, BA Raby, Q Hamid, ...","Pharmacogenetics and genomics 22 (10), 758",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2967331245952477410,37,2012
AI in medicine: The spectrum of challenges from managed care to molecular medicine,RB Altman,"AI magazine 20 (3), 67-67",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5729987137012112443,37,1999
Evidence for clinical implementation of pharmacogenomics in cardiac drugs,"AL Kaufman, J Spitz, M Jacobs, M Sorrentino, S Yuen, K Danahey, ...","Mayo Clinic Proceedings 90 (6), 716-729",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10609013034919376049,36,2015
Mining biochemical information: Lessons taught by the ribosome,"M Whirl-Carrillo, IS Gabashvili, M Bada, DR Banatao, RB Altman","Rna 8 (3), 279-289",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=557161007289208350,36,2002
Lamprey: tracking users on the World Wide Web.,"RM Felciano, RB Altman","Proceedings of the AMIA Annual Fall Symposium, 757",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8759655488647887367,36,1996
Reuse with PROTÉGÉ-II: From elevators to ribosomes,"JH Gennari, RB Altman, MA Musen","ACM SIGSOFT Software Engineering Notes 20 (SI), 72-80",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14590949148700535879,36,1995
Achieving high-sensitivity for clinical applications using augmented exome sequencing,"A Patwardhan, J Harris, N Leng, G Bartha, DM Church, S Luo, ...","Genome medicine 7 (1), 71",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17816056608840655881,35,2015
PharmGKB summary: phenytoin pathway,"CF Thorn, M Whirl-Carrillo, JS Leeder, TE Klein, RB Altman","Pharmacogenetics and genomics 22 (6), 466",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13628638064402868301,35,2012
Molecular counting: from noninvasive prenatal diagnostics to whole-genome haplotyping,HMC Fan,Stanford University,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3831436260739011781,35,2011
Clustering protein environments for function prediction: finding PROSITE motifs in 3D,"S Yoon, JC Ebert, EY Chung, G De Micheli, RB Altman","BMC bioinformatics 8 (4), S10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12875193343758452882,35,2007
Integrated text mining and chemoinformatics analysis associates diet to health benefit at molecular level,"K Jensen, G Panagiotou, I Kouskoumvekaki","PLoS computational biology 10 (1), e1003432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1545606952142667333,34,2014
Indexing pharmacogenetic knowledge on the World Wide Web,"RB Altman, DA Flockhart, ST Sherry, DE Oliver, DL Rubin, TE Klein","Pharmacogenetics and Genomics 13 (1), 3-5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8275473139087167954,34,2003
"Reuse, CORBA, and knowledge-based systems","JH Gennari, H Cheng, RB Altman, MA Musen","International Journal of Human-Computer Studies 49 (4), 523-546",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9643940010853795100,34,1998
Share and share alike,MD RUSS ALTMAN,,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9835257946615680415,34,1991
Genotype-Guided Dosing of Vitamin K Antagonists (Dr. Maitland-Van Der Zee and colleagues reply),"AH Maitland-van Der Zee, A De Boer, VG Manolopoulos","New England Journal of Medicine 370 (18), 1765-1766",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4083364484055979774,33,2014
Representing genetic sequence data for pharmacogenomics: an evolutionary approach using ontological and relational models,"DL Rubin, F Shafa, DE Oliver, M Hewett, RB Altman","Bioinformatics 18 (suppl_1), S207-S215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4449951332827029983,33,2002
Constrained global optimization for estimating molecular structure from atomic distances,"GA Williams, JM Dugan, RB Altman","Journal of computational biology 8 (5), 523-547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11813472479603012630,33,2001
OrderRex: clinical order decision support and outcome predictions by data-mining electronic medical records,"JH Chen, T Podchiyska, RB Altman","Journal of the American Medical Informatics Association 23 (2), 339-348",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17482352748790181300,32,2015
K-means for parallel architectures using all-prefix-sum sorting and updating steps,"KJ Kohlhoff, VS Pande, RB Altman","IEEE Transactions on Parallel and Distributed Systems 24 (8), 1602-1612",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12372238006710606447,32,2012
Using ODIN for a PharmGKB revalidation experiment,"F Rinaldi, S Clematide, Y Garten, M Whirl-Carrillo, L Gong, JM Hebert, ...",Database 2012,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12114993018864944120,32,2012
CAMPAIGN: an open-source library of GPU-accelerated data clustering algorithms,"KJ Kohlhoff, MH Sosnick, WT Hsu, VS Pande, RB Altman","Bioinformatics 27 (16), 2321-2322",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6066653719192538268,32,2011
Modeling and analyzing biomedical processes using workflow/Petri Net models and tools.,"M Peleg, SW Tu, A Manindroo, RB Altman","Medinfo 2004, 74-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9397930737649325058,32,2004
Identification of promoter regions in the human genome by using a retroviral plasmid library-based functional reporter gene assay,"S Khambata-Ford, Y Liu, C Gleason, M Dickson, RB Altman, S Batzoglou, ...","Genome research 13 (7), 1765-1774",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10379759656636132865,32,2003
The dependence of a protein solution structure on the quality of the input NMR data. Application of the double-iterated Kalman filter technique to oxytocin,"R Pachter, RB Altman, O Jardetzky","Journal of Magnetic Resonance (1969) 89 (3), 578-584",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6417806204427891366,32,1990
"PharmGKB Summary-Very Important Pharmacogene Information for Cytochrome P-450, Family 2, Subfamily A, polypeptide 6 (CYP2A6)","EM McDonagh, C Wassenaar, SP David, RF Tyndale, RB Altman, ...","Pharmacogenetics and genomics 22 (9), 695",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1477330218487791347,31,2012
"The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge","AE Hodge, RB Altman, TE Klein","Clinical Pharmacology & Therapeutics 81 (1), 21-24",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10524403897169611704,31,2007
PharmGKB summary: gemcitabine pathway,"ML Alvarellos, J Lamba, K Sangkuhl, CF Thorn, L Wang, DJ Klein, ...","Pharmacogenetics and genomics 24 (11), 564",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9146970429697675429,30,2014
Personal genomic measurements: the opportunity for information integration,RB Altman,"Clinical Pharmacology & Therapeutics 93 (1), 21-23",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14127467135265976944,30,2013
"Interpretome: a freely available, modular, and secure personal genome interpretation engine","KJ Karczewski, RP Tirrell, P Cordero, NP Tatonetti, JT Dudley, K Salari, ...","Biocomputing 2012, 339-350",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1524353034922692509,30,2012
PharmGKB summary: citalopram pharmacokinetics pathway,"K Sangkuhl, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (11), 769",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8448219262138034260,30,2011
"iTools: a framework for classification, categorization and integration of computational biology resources","ID Dinov, D Rubin, W Lorensen, J Dugan, J Ma, S Murphy, B Kirschner, ...","PLoS One 3 (5), e2265",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9473108470559787126,30,2008
Commentaries on “Informatics and medicine: from molecules to populations”,"RB Altman, R Balling, JF Brinkley, E Coiera, F Consorti, MA Dhansay, ...","Methods of information in medicine 47 (04), 296-317",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12641189566841844060,30,2008
Combining molecular dynamics and machine learning to improve protein function recognition,"DS Glazer, RJ Radmer, RB Altman","Biocomputing 2008, 332-343",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17738261894190046715,30,2008
Extracting subject demographic information from abstracts of randomized clinical trial reports,"R Xu, Y Garten, KS Supekar, AK Das, RB Altman, AM Garber",Medinfo 2007: Proceedings of the 12th World Congress on Health (Medical …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8811490298081441788,30,2007
A functional analysis of disease‐associated mutations in the androgen receptor gene,"SD Mooney, TE Klein, RB Altman, MA Trifiro, B Gottlieb","Nucleic acids research 31 (8), e42-e42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9196006697212901276,30,2003
Using imperfect secondary structure predictions to improve molecular structure computations.,"CC Chen, JP Singh, RB Altman","Bioinformatics (Oxford, England) 15 (1), 53-65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14748486091101412619,30,1999
Predicting inpatient clinical order patterns with probabilistic topic models vs conventional order sets,"JH Chen, MK Goldstein, SM Asch, L Mackey, RB Altman","Journal of the American Medical Informatics Association 24 (3), 472-480",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17100515526805011552,29,2017
Learning the structure of biomedical relationships from unstructured text,"B Percha, RB Altman","PLoS computational biology 11 (7), e1004216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10527042546548251486,29,2015
Relating essential proteins to drug side-effects using canonical component analysis: a structure-based approach,"T Liu, RB Altman","Journal of chemical information and modeling 55 (7), 1483-1494",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18122864365256188427,28,2015
Pharmacogenomics: will the promise be fulfilled?,"RB Altman, HK Kroemer, CA McCarty, MJ Ratain, D Roden","Nature Reviews Genetics 12 (1), 69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3360624205819369768,28,2011
Defining bioinformatics and structural bioinformatics,"RB Altman, JM Dugan","Structural Bioinformatics 44, 1-14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12111916052791567920,28,2003
Using a measure of structural variation to define a core for the globins,"M Gerstein, RB Altman","Bioinformatics 11 (6), 633-644",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10873021804216189800,28,1995
Finding an average core structure: application to the globins.,"RB Altman, M Gerstein","ISMB 2, 19-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6759858402084624872,28,1994
PharmGKB: a worldwide resource for pharmacogenomic information,"JM Barbarino, M Whirl‐Carrillo, RB Altman, TE Klein","Wiley Interdisciplinary Reviews: Systems Biology and Medicine 10 (4), e1417",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5845693321089254963,27,2018
A research roadmap for next-generation sequencing informatics,"RB Altman, S Prabhu, A Sidow, JM Zook, R Goldfeder, D Litwack, ...","Science translational medicine 8 (335), 335ps10-335ps10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17770321506071829587,27,2016
Integrating systems biology sources illuminates drug action,"A Gottlieb, RB Altman","Clinical Pharmacology & Therapeutics 95 (6), 663-669",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17321324756859867630,27,2014
Qualitative models of molecular function: linking genetic polymorphisms of tRNA to their functional sequelae,"M Peleg, IS Gabashvili, RB Altman","Proceedings of the IEEE 90 (12), 1875-1886",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=44300056746853453,27,2002
Pattern recognition of genomic features with microarrays: site typing of Mycobacterium tuberculosis strains.,"S Raychaudhuri, JM Stuart, X Liu, PM Small, RB Altman","Ismb, 286-295",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17588585558856013203,27,2000
A prototype molecular interactive collaborative environment (MICE),"PE Bourne, M Gribskov, G Johnson, J Moreland, H Weissig","Pacific Symposium on Biocomputing, 118-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=178088870850280404,27,1998
Decaying relevance of clinical data towards future decisions in data-driven inpatient clinical order sets,"JH Chen, M Alagappan, MK Goldstein, SM Asch, RB Altman","International journal of medical informatics 102, 71-79",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15299626902301765245,26,2017
PharmGKB summary: methylene blue pathway,"EM McDonagh, JM Bautista, I Youngster, RB Altman, TE Klein","Pharmacogenetics and genomics 23 (9), 498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1276427688369336446,26,2013
Improving the prediction of pharmacogenes using text-derived drug-gene relationships,"Y Garten, NP Tatonetti, RB Altman","Biocomputing 2010, 305-314",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4991285059628578475,26,2010
Prediction of calcium-binding sites by combining loop-modeling with machine learning,"T Liu, RB Altman","BMC structural biology 9 (1), 72",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17137474496898385910,26,2009
Sophia: Providing basic knowledge services with a common DBMS,"NF Abernethy, RB Altman",Proceedings of the 5th International Workshop on Knowledge Represenation …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3386811163727654380,26,1998
Constraint satisfaction techniques for modeling large complexes: application to the central domain of 16S ribosomal RNA.,"RB Altman, B Weiser, HF Noller","ISMB, 10-18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10434411136344326465,26,1994
Ranking adverse drug reactions with crowdsourcing,"A Gottlieb, R Hoehndorf, M Dumontier, RB Altman","Journal of medical Internet research 17 (3), e80",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4855692312265578747,25,2015
Direct‐to‐consumer genetic testing: failure is not an option,RB Altman,"Clinical Pharmacology & Therapeutics 86 (1), 15-17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13165109359043771194,25,2009
Coplanar and coaxial orientations of RNA bases and helices,"A Laederach, JM Chan, A Schwartzman, E Willgohs, RB Altman","Rna 13 (5), 643-650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10882616803961901714,25,2007
Updating a bibliography using the related articles function within PubMed.,"X Liu, RB Altman","Proceedings of the AMIA Symposium, 750",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11550791140960980072,25,1998
PharmGKB summary: venlafaxine pathway,"K Sangkuhl, JC Stingl, M Turpeinen, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (1), 62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10030843938424169775,24,2014
PharmGKB summary: mycophenolic acid pathway,"V Lamba, K Sangkuhl, K Sanghavi, A Fish, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (1), 73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3018453825567692432,24,2014
Pathway analysis of genome-wide data improves warfarin dose prediction,"R Daneshjou, NP Tatonetti, KJ Karczewski, H Sagreiya, S Bourgeois, ...","BMC genomics 14 (3), S11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14255999334850713193,24,2013
PharmGKB summary: very important pharmacogene information for G6PD,"EM McDonagh, CF Thorn, JM Bautista, I Youngster, RB Altman, TE Klein","Pharmacogenetics and genomics 22 (3), 219",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18064854199692432007,24,2012
The SeqFEATURE library of 3D functional site models: comparison to existing methods and applications to protein function annotation,"S Wu, MP Liang, RB Altman","Genome biology 9 (1), R8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16892813247095442431,24,2008
Choosing SNPs using feature selection,"TM Phuong, Z Lin, RB Altman","Journal of bioinformatics and computational biology 4 (02), 241-257",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8097061773216975546,24,2006
"SOPHIA: a flexible, web-based knowledge server","NF Abernethy, JJ Wu, M Hewett, RB Altman","IEEE Intelligent Systems and Their Applications 14 (4), 79-85",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7766187662839070125,24,1999
Shape-based models for interactive segmentation of medical images,"KP Hinshaw, RB Altman, JF Brinkley","Medical Imaging 1995: Image Processing 2434, 771-780",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16906811475256142826,24,1995
PROTEAN: A new method for deriving solution structures of proteins,"B Duncan, BG Buchanan, B Hayes-Roth, O Lichtarge, RP Altman, ...","Bulletin of Magnetic Resonance 8 (3/4), 111-119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3186360703394894083,24,1986
Knowledge-based fragment binding prediction,"GW Tang, RB Altman","PLoS computational biology 10 (4), e1003589",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2520669890363460898,23,2014
"PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8","CL Aquilante, M Niemi, L Gong, RB Altman, TE Klein","Pharmacogenetics and genomics 23 (12), 721",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2821358763168128606,23,2013
Challenges in the pharmacogenomic annotation of whole genomes,"RB Altman, M Whirl‐Carrillo, TE Klein","Clinical Pharmacology & Therapeutics 94 (2), 211-213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14847955112708530253,23,2013
RNA secondary structure as a reusable interface to biological information resources,"RM Felciano, RO Chen, RB Altman","Gene 190 (2), GC59-GC70",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3495206888353436835,23,1997
Extraction of SNOMED concepts from medical record texts.,"DE Oliver, RB Altman","Proceedings of the Annual Symposium on Computer Application in Medical Care, 179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11607748031826422920,23,1994
Towards a standard query model for sharing decision-support applications.,"W Sujansky, R Altman","Proceedings of the Annual Symposium on Computer Application in Medical Care, 325",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12788876253365309314,23,1994
Constraints on biological mechanism from disease comorbidity using electronic medical records and database of genetic variants,"SC Bagley, M Sirota, R Chen, AJ Butte, RB Altman","PLoS computational biology 12 (4), e1004885",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8752800357398772150,22,2016
"Coherent functional modules improve transcription factor target identification, cooperativity prediction, and disease association","KJ Karczewski, M Snyder, RB Altman, NP Tatonetti","PLoS genetics 10 (2), e1004122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14963097770397523312,22,2014
Identifying druggable targets by protein microenvironments matching: application to transcription factors,"T Liu, RB Altman","CPT: pharmacometrics & systems pharmacology 3 (1), 1-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10764173810206269140,22,2014
Data re-identification: societal safeguards,"RB Altman, EW Clayton, IS Kohane, BA Malin, DM Roden","Science 339 (6123), 1032-1033",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8993335418491772103,22,2013
RNA molecules with conserved catalytic cores but variable peripheries fold along unique energetically optimized pathways,"S Mitra, A Laederach, BL Golden, RB Altman, M Brenowitz","Rna 17 (8), 1589-1603",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5653322609696748089,22,2011
"PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2","DS Berlin, K Sangkuhl, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (5), 308",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1155442431505651609,22,2011
Confidentiality in genome research,"Z Lin, RB Altman, AB Owen","Science 313 (5786), 441-442",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9617029189501597989,22,2006
Inclusion of textual documentation in the analysis of multidimensional data sets: application to gene expression data,"S Raychaudhuri, H Schütze, RB Altman","Machine Learning 52 (1-2), 119-145",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15666192841435293462,22,2003
Characterizing oriented protein structural sites using biochemical properties.,"SC Bagley, L Wei, C Cheng, RB Altman","ISMB, 12-20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16300282739669262120,22,1995
Artificial intelligence (AI) systems for interpreting complex medical datasets,RB Altman,"Clinical Pharmacology & Therapeutics 101 (5), 585-586",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=844896782639697858,21,2017
Sequence to medical phenotypes: a framework for interpretation of human whole genome DNA sequence data,"FE Dewey, ME Grove, JR Priest, D Waggott, P Batra, CL Miller, M Wheeler, ...","PLoS genetics 11 (10), e1005496",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14707496137435117237,21,2015
Using “big data” to dissect clinical heterogeneity,"RB Altman, EA Ashley","Circulation 131 (3), 232-233",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14015901890735633717,21,2015
SLC19A1 pharmacogenomics summary,"SW Yee, L Gong, I Badagnani, KM Giacomini, TE Klein, RB Altman","Pharmacogenetics and genomics 20 (11), 708",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4731492108747033232,21,2010
The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB),"RP Owen, TE Klein, RB Altman","Clinical Pharmacology & Therapeutics 82 (4), 472-475",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12877471529522888250,21,2007
Biomedical informatics training at Stanford in the 21st century,"RB Altman, TE Klein","Journal of biomedical informatics 40 (1), 55-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18255610699116590493,21,2007
Comparison of the NMR solution structures of cyclosporin A determined by different techniques,"R Pachter, RB Altman, J Czaplicki, O Jardetzky","Journal of Magnetic Resonance (1969) 92 (3), 468-479",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11601106904277885853,21,1991
Informatics: Make sense of health data,"JH Elliott, J Grimshaw, R Altman, L Bero, SN Goodman, D Henry, ...","Nature News 527 (7576), 31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18265288070508827698,20,2015
Mice lacking the β2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemia,"RE White, C Palm, L Xu, E Ling, M Ginsburg, JD Bernie Jr, R Han, ...","ASN neuro 4 (5), AN20110020",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9629208056582768254,20,2012
TOWARDS A CYTOKlNE-CELL INTERACTION KNOWLEDGEBASE OF THE ADAPTIVE IMMUNE SYSTEM,"SS SHEN-ORR, O Goldberger, Y Garten, Y Rosenberg-Hasson, ...","Biocomputing 2009, 439-450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4289864031919829236,20,2009
Ribosomal dynamics inferred from variations in experimental measurements,"IS Gabashvili, M Whirl-Carrillo, M Bada, DR Banatao, RB Altman","Rna 9 (11), 1301-1307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5702784429495602696,20,2003
Calculation of the relative geometry of tRNAs in the ribosome from directed hydroxyl-radical probing data,"S Joseph, ML Whirl, D Kondo, HF Noller, RB Altman","RNA 6 (2), 220-232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10785881293541336734,20,2000
Probabilistic structure calculations: a three-dimensional tRNA structure from sequence correlation data.,RB Altman,"Ismb, 12-20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17308804506523959991,20,1993
Principles of pharmacogenetics and pharmacogenomics,"RB Altman, D Flockhart, DB Goldstein",Cambridge University Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13071330181211471844,19,2012
Conserved features in the active site of nonhomologous serine proteases,"SC Bagley, RB Altman","Folding and Design 1 (5), 371-379",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2547534169783683262,19,1996
Personalization in practice,"R Iyengar, RB Altman, O Troyanskya, GA FitzGerald","Science 350 (6258), 282-283",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15740201319334274288,18,2015
Take a stand on AI weapons,S Russell,"Nature 521 (7553), 415-416",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5238365545628588803,18,2015
Introduction to translational bioinformatics collection,RB Altman,"PLoS computational biology 8 (12), e1002796",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12407495805161281844,18,2012
The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables,"H Sagreiya, RB Altman","Journal of biomedical informatics 43 (5), 747-751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13876506489173849430,18,2010
An integrative method for scoring candidate genes from association studies: application to warfarin dosing,"NP Tatonetti, JT Dudley, H Sagreiya, AJ Butte, RB Altman","BMC bioinformatics 11 (9), S9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12616254009175217798,18,2010
Very important pharmacogene summary: sulfotransferase 1A1,"M Hildebrandt, A Adjei, R Weinshilboum, JA Johnson, DS Berlin, TE Klein, ...","Pharmacogenetics and genomics 19 (6), 404-406",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16369838471519473081,18,2009
Standardized representations of the literature: combining diverse sources of ribosomal data.,"RB Altman, NF Abernethy, RO Chen","Ismb, 15-24",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3501720589911009230,18,1997
A probabilistic approach to determining biological structure: integrating uncertain data sources,RB Altman,"International journal of human-computer studies 42 (6), 593-616",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14490556771535110527,18,1995
Compositional characteristics of relatively disordered regions in proteins,"R Altman, C Hughes, D Zhao, O Jardetsky","Prot. Pept. Lett 1, 120-127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7658085431877906400,18,1994
Developing retinal biomarkers of neurological disease: an analytical perspective,"IJC MacCormick, G Czanner, B Faragher","Biomarkers in medicine 9 (7), 691-701","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14273569261646611129,7477750815238490881,6900292622482277931",17,2015
Automated physician order recommendations and outcome predictions by data-mining electronic medical records,"JH Chen, RB Altman","AMIA Summits on Translational Science proceedings 2014, 206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17701620490181922974,17,2014
Vascular endothelial growth factor pathway,"ML Maitland, XJ Lou, J Ramirez, AA Desai, DS Berlin, HL McLeod, ...","Pharmacogenetics and genomics 20 (5), 346",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6881873347445350730,17,2010
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme,"CF Thorn, TE Klein, RB Altman","Pharmacogenetics and genomics 20 (2), 143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17349414648754248030,17,2010
Hierarchical organization of molecular structure computations,"CC Chen, JASWPAL SINGH, RB Altman","Journal of Computational Biology 5 (3), 409-422",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7015010841243994614,17,1998
Association of omics features with histopathology patterns in lung adenocarcinoma,"KH Yu, GJ Berry, DL Rubin, C Ré, RB Altman, M Snyder","Cell systems 5 (6), 620-627. e3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15944033058865330966,16,2017
2010 Translational bioinformatics year in review,"RB Altman, KS Miller","Journal of the American Medical Informatics Association 18 (4), 358-366",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16443018697493717333,16,2011
Intelligent Systems in Molecular Biology,"PA Pevzner, SH Sze","AAAI Press, La Jolla, CA","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18125023065853768622,17857688372059998194,10069963215203679012",16,2000
Using Metacomputing Tools To Facilitate Large-Scale Analyses of Biological Databases,"A Waugh, GA Williams, L Wei, RB Altman","Biocomputing 2001, 360-371",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=452552982859481597,16,2000
"PharmGKB Summary: Efavirenz Pathway, Pharmacokinetics (PK)","EM McDonagh, JL Lau, M Alvarellos, RB Altman, TE Klein","Pharmacogenetics and genomics 25 (7), 363",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9337701310491973427,15,2015
PharmGKB summary: very important pharmacogene information for CYP4F2,"ML Alvarellos, K Sangkuhl, R Daneshjou, M Whirl-Carrillo, RB Altman, ...","Pharmacogenetics and genomics 25 (1), 41",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5979904416074544453,15,2015
PATH-SCAN: a reporting tool for identifying clinically actionable variants,"R Daneshjou, Z Zappala, KIM KUKURBA, SM Boyle, KE Ormond, ...","Biocomputing 2014, 229-240",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3032756780800448948,15,2014
An NIH white paper by the QSP workshop group,"PK Sorger, SR Allerheiligen, DR Abernethy, RB Altman, KL Brouwer, ...",Quantitative and Systems Pharmacology in the Post-genomic Era: New …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7361944800700350104,15,2011
Maternal–fetal and neonatal pharmacogenomics: a review of current literature,"YJ Blumenfeld, MF Reynolds-May, RB Altman, YY El-Sayed","Journal of Perinatology 30 (9), 571",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2077402728746602368,15,2010
Methods for displaying macromolecular structural uncertainty: application to the globins,"RB Altman, C Hughes, MB Gerstein","Journal of molecular graphics 13 (3), 142-152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10047781137311256220,15,1995
PharmGKB summary: very important pharmacogene information for PTGS2,"CF Thorn, T Grosser, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (9), 607",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9458664198699232372,14,2011
Using pre-existing microarray datasets to increase experimental power: application to insulin resistance,"BJ Daigle Jr, A Deng, T McLaughlin, SW Cushman, MC Cam, G Reaven, ...","PLoS computational biology 6 (3), e1000718",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4426942814290869010,14,2010
New feature: pathways and important genes from PharmGKB,"M Eichelbaum, RB Altman, M Ratain, TE Klein","Pharmacogenetics and genomics 19 (6), 403",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13959714216696150772,14,2009
M-BISON: microarray-based integration of data sources using networks,"BJ Daigle, RB Altman","BMC bioinformatics 9 (1), 214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3753174600492592316,14,2008
Exclusion methods for the determination of protein structure from experimental data.,RB Altman,,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16293272193081553914,14,1990
Mechanism of RNA virus assembly and disassembly,"SC Harrison, PK Sorger, PG Stockley, J Hogle, R Altman, RK Strong","Positive strand RNA viruses. Alan R. Liss, Inc., New York, NY, 379-395",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18290506786009708843,14,1987
A global network of biomedical relationships derived from text,"B Percha, RB Altman","Bioinformatics 34 (15), 2614-2624",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13816875104201062809,13,2018
"PharmGKB Summary: Isoniazid Pathway, Pharmacokinetics (PK)","DJ Klein, S Boukouvala, EM McDonagh, SR Shuldiner, N Laurieri, ...","Pharmacogenetics and genomics 26 (9), 436",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10954351315956730241,13,2016
An ontology for autism spectrum disorder (ASD) to infer ASD phenotypes from autism diagnostic interview-revised data,"O Mugzach, M Peleg, SC Bagley, SJ Guter, EH Cook, RB Altman","Journal of biomedical informatics 56, 333-347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10625783600311230608,13,2015
Variations in the binding pocket of an inhibitor of the bacterial division protein FtsZ across genotypes and species,"A Miguel, J Hsin, T Liu, G Tang, RB Altman, KC Huang","PLoS computational biology 11 (3), e1004117",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=522503813471216081,13,2015
"PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics","EM McDonagh, CF Thorn, JT Callaghan, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (9), 464",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10892656481806024562,13,2014
PharmGKB summary: very important pharmacogene information for epidermal growth factor receptor (EGFR),"U Hodoglugil, MW Carrillo, JM Hebert, N Karachaliou, RC Rosell, ...","Pharmacogenetics and genomics 23 (11), 636",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5073898189445564849,13,2013
Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing,"RB Altman, N Benowitz, D Gurwitz, J Lunshof, M Relling, E Wieben, ...","Pharmacogenomics 8 (5), 519",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5290608835262747901,13,2007
Promises of text processing: natural language processing meets AI,"JT Chang, RB Altman","Drug discovery today 19 (7), 992-993",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12443721118176408247,13,2002
Parallel protein structure determination from uncertain data,"CC Chen, JP Singh, WB Poland, RB Altman","Proceedings of the 1994 ACM/IEEE conference on Supercomputing, 570-579",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2065042089381622344,13,1994
A probabilistic algorithm for calculating structure: borrowing from simulated annealing,RB Altman,"Uncertainty in Artificial Intelligence, 23-31","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6949069470421462923,4480255467417834908",13,1993
Improving the explainability of Random Forest classifier-user centered approach.,"D Petkovic, RB Altman, M Wong, A Vigil","PSB, 204-215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16578657946055502967,12,2018
Interpreting the CYP2D6 results from the international tamoxifen pharmacogenetics consortium,"MA Province, RB Altman, TE Klein","Clinical Pharmacology & Therapeutics 96 (2), 144-146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6057629665479692722,12,2014
PharmGKB summary: dopamine receptor D2,"H Mi, PD Thomas, HZ Ring, R Jiang, K Sangkuhl, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (6), 350",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8075091266656133323,12,2011
Remote thioredoxin recognition using evolutionary conservation and structural dynamics,"GW Tang, RB Altman","Structure 19 (4), 461-470",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10179944176990996833,12,2011
Probabilistic constraint satisfaction with non-Gaussian noise,"RB Altman, CC Chen, WB Poland, JP Singh","Uncertainty Proceedings 1994, 15-22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15736593877276509080,12,1994
"PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics","ML Alvarellos, EM McDonagh, S Patel, HL McLeod, RB Altman, TE Klein","Pharmacogenetics and genomics 25 (12), 622",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=139798360651692822,11,2015
PharmGKB Summary: Very Important Pharmacogene Information for Human Leukocyte Antigen B (HLA-B),"JM Barbarino, DL Kroetz, TE Klein, RB Altman","Pharmacogenetics and genomics 25 (4), 205",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14494424286399898750,11,2015
Predicting cancer drug response: advancing the DREAM,RB Altman,"Cancer discovery 5 (3), 237-238",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5249060607700226765,11,2015
Genome-wide Association Study of Virologic Response with Efavirenz-or Abacavir-containing Regimens in AIDS Clinical Trials Group Protocols,"DS Lehmann, HJ Ribaudo, ES Daar, RM Gulick, RH Haubrich, ...","Pharmacogenetics and genomics 25 (2), 51",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17583897741027197284,11,2015
Simbios: an NIH national center for physics-based simulation of biological structures,"SL Delp, JP Ku, VS Pande, MA Sherman, RB Altman","Journal of the American Medical Informatics Association 19 (2), 186-189",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=41457685853163058,11,2011
KCNH2 pharmacogenomics summary,"C Oshiro, CF Thorn, DM Roden, TE Klein, RB Altman","Pharmacogenetics and genomics 20 (12), 775",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3105584541853411147,11,2010
Identification of recurring protein structure microenvironments and discovery of novel functional sites around CYS residues,"S Wu, T Liu, RB Altman","BMC structural biology 10 (1), 4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9709919560683831585,11,2010
Integrating large-scale genotype and phenotype data,"T Hernandez-Boussard, M Woon, TE Klein, RB Altman","Omics: a journal of integrative biology 10 (4), 545-554",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16313143806135259344,11,2006
Automated diagnosis of data-model conflicts using metadata,"RO Chen, RB Altman","Journal of the American Medical Informatics Association 6 (5), 374-392",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3884920229439727643,11,1999
An evaluation of the TransFER model for sharing clinical decision-support applications.,"W Sujansky, R Altman","Proceedings of the AMIA Annual Fall Symposium, 468",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3997756577221972307,11,1996
Application of constraint satisfaction techniques to the determination of protein tertiary structure,"JF Brinkley, C Cornelius, RB Altman, B Hayes-Roth, O Lichtarge, ...",Stanford University,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17599873463429603850,11,1986
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel …,"TO Bergmeijer, JL Reny, RE Pakyz, L Gong, JP Lewis, EY Kim, D Aradi, ...","American heart journal 198, 152-159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1382516343143419185,10,2018
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges,"R Daneshjou, Y Wang, Y Bromberg, S Bovo, PL Martelli, G Babbi, ...","Human mutation 38 (9), 1182-1192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10297714936762434474,10,2017
"Computing disease incidence, prevalence and comorbidity from electronic medical records","SC Bagley, RB Altman","Journal of biomedical informatics 63, 108-111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7352433352968320494,10,2016
Signal detection algorithms to identify drug effects and drug interactions,"N Tatonetti, RB Altman, GH Fernald","US Patent 9,305,267",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1693019045034496652,10,2016
Dynamically evolving clinical practices and implications for predicting medical decisions,"JH Chen, MK Goldstein, SM Asch, RB Altman","Biocomputing 2016: Proceedings of the Pacific Symposium, 195-206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2623254144870450291,10,2016
High precision prediction of functional sites in protein structures,"L Buturovic, M Wong, GW Tang, RB Altman, D Petkovic","PloS one 9 (3), e91240",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11438008617756785965,10,2014
"PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics","D Lowenberg, CF Thorn, Z Desta, DA Flockhart, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (2), 133",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13069337941943432062,10,2014
PharmGKB: very important pharmacogene–HMGCR,"MW Medina, K Sangkuhl, TE Klein, RB Altman","Pharmacogenetics and genomics 21 (2), 98",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3566152470490457528,10,2011
Extraction of genotype-phenotype-drug relationships from text: from entity recognition to bioinformatics application,"A Coulet, N Shah, L Hunter, C Barral, RB Altman","Biocomputing 2010, 485-487",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=130381196026088962,10,2010
Pathway-based approaches to pharmacogenomics,"CF Thorn, M Whirl-Carrillo, TE Klein, RB Altman","Current Pharmacogenomics 5 (1), 79-86",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10788998257511869453,10,2007
Literature review on patient-friendly documentation systems,"H Åhlfeldt, L Borin, N Grabar, C Hallett, D Hardcastle, D Kokkinakis, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1029338254844407147,10,2006
Using surface envelopes for discrimination of molecular models,"JM Dugan, RB Altman","Protein science 13 (1), 15-24",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17550929427820877626,10,2004
Genetic sequence data for pharmacogenomics.,RB Altman,"Current opinion in drug discovery & development 6 (3), 297-303",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10619537597050255679,10,2003
Constraining volume by matching the moments of a distance distribution,"CC Chen, RO Chen, RB Altman","Bioinformatics 12 (4), 319-326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14068944254804736827,10,1996
Partial Compilation of Strategic Knowledge.,"RB Altman, BG Buchanan","AAAI, 399-404",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3592044762122873913,10,1987
Association of the polygenic scores for personality traits and response to selective serotonin reuptake inhibitors in patients with major depressive disorder,"AT Amare, KO Schubert, F Tekola-Ayele, YH Hsu, K Sangkuhl, G Jenkins, ...","Frontiers in psychiatry 9, 65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10627713775019888645,9,2018
"A dynamic map for learning, communicating, navigating and improving therapeutic development","J Wagner, AM Dahlem, LD Hudson, SF Terry, RB Altman, CT Gilliland, ...","Nature Reviews Drug Discovery 17 (2), 150",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13040655392740940541,9,2018
Expanding a radiology lexicon using contextual patterns in radiology reports,"B Percha, Y Zhang, S Bozkurt, D Rubin, RB Altman, CP Langlotz","Journal of the American Medical Informatics Association 25 (6), 679-685",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15321428995149434680,9,2018
PharmGKB summary: sorafenib pathways,"L Gong, MM Giacomini, C Giacomini, ML Maitland, RB Altman, TE Klein","Pharmacogenetics and genomics 27 (6), 240",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12814233812958642355,9,2017
PharmGKB summary: zidovudine pathway,"Y Ghodke, PL Anderson, K Sangkuhl, J Lamba, RB Altman, TE Klein","Pharmacogenetics and genomics 22 (12), 891",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11897649480185619640,9,2012
DNATwist: A Web‐Based Tool for Teaching Middle and High School Students About Pharmacogenomics,"DS Berlin, MG Person, A Mittal, MA Oppezzo, DB Chin, B Starr, TE Klein, ...","Clinical Pharmacology & Therapeutics 87 (4), 393-395",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17463181386903637999,9,2010
A resource to acquire and summarize pharmacogenetics knowledge in the literature.,"DL Rubin, MW Carrillo, M Woon, J Conroy, TE Klein, RB Altman","Medinfo, 793-797",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4047269963222662018,9,2004
A programming course in bioinformatics for computer and information science students,"RB Altman, J Koza","Proc. Pac. Symp. Biocomput, 73-84",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=584659897454904805,9,1996
Bridging the representational heterogeneity of clinical databases,"W Sujansky, R Altman",Submitted to AAAI 1994 Spring Symposium: Artificial Intelligence in Medicine …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16667877257896928413,9,1994
Probabilistic constraint satisfaction with structural models: application to organ modeling by radial contours.,"RB Altman, JF Brinkley","Proceedings of the Annual Symposium on Computer Application in Medical Care, 492",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1485719043620499291,9,1993
The heuristic refinement method for deriving solution structures of proteins,"BG Buchanan, B Hayes-Roth, O Lichtarge, R Altman, J Brinkley, M Hewett, ...","Department of Computer Science, Stanford University, Report No, STAN-CS-86-115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12250314171365804782,9,1986
"Jardetzky, 0.(1991) Eur","C Arrowsmith, R Pachter, R Altman","J. Biochem 202, 53-66",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6327050911592730206,9,0
"Application of a dynamic map for learning, communicating, navigating, and improving therapeutic development","JA Wagner, AM Dahlem, LD Hudson, SF Terry, RB Altman, CT Gilliland, ...","Clinical and translational science 11 (2), 166-174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16230605245525816335,8,2018
Opportunities for developing therapies for rare genetic diseases: focus on gain-of-function and allostery,"B Chen, RB Altman","Orphanet journal of rare diseases 12 (1), 61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13109602185481683938,8,2017
"PharmGKB summary: voriconazole pathway, pharmacokinetics","JM Barbarino, A Owusu-Obeng, TE Klein, RB Altman","Pharmacogenetics and genomics 27 (5), 201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8972148800397042605,8,2017
Imputing gene expression to maximize platform compatibility,"W Zhou, L Han, RB Altman","Bioinformatics 33 (4), 522-528",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3780261083398442580,8,2016
PharmGKB summary: very important pharmacogene information for RYR1,"ML Alvarellos, RM Krauss, RA Wilke, RB Altman, TE Klein","Pharmacogenetics and genomics 26 (3), 138",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9513025814325005935,8,2016
Unmet needs: Research helps regulators do their jobs,"RB Altman, N Khuri, M Salit, KM Giacomini","Science translational medicine 7 (315), 315ps22-315ps22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=794480765921034715,8,2015
High resolution prediction of calcium-binding sites in 3D protein structures using FEATURE,"W Zhou, GW Tang, RB Altman","Journal of chemical information and modeling 55 (8), 1663-1672",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14122577138479414672,8,2015
Data-mining electronic medical records for clinical order recommendations: wisdom of the crowd or tyranny of the mob?,"JH Chen, RB Altman","AMIA Summits on Translational Science Proceedings 2015, 435",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15376579405342866472,8,2015
Mining for clinical expertise in (undocumented) order sets to power an order suggestion system,"JH Chen, RB Altman","AMIA Summits on Translational Science Proceedings 2013, 34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16670938152850794605,8,2013
PharmGKB summary-very important pharmacogene information for GSTT1,"CF Thorn, Y Ji, RM Weinshilboum, RB Altman, TE Klein","Pharmacogenetics and genomics 22 (8), 646",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5115336486003895329,8,2012
Teaching computers to read the pharmacogenomics literature… so you don’t have to,"Y Garten, RB Altman","Pharmacogenomics 11 (4), 515-518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13705552210361023815,8,2010
The BioCreative II-critical assessment for information extraction in biology challenge,"M Krallinger, A Morgan, L Smith, F Leitner, L Tanabe, J Wilbur, ...","Genome Biology 9 (2), S10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2739722986961442507,8,2008
An automated system for generating comparative disease profiles and making diagnoses,"L Wei, RB Altman","IEEE Transactions on Neural Networks 15, 597",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13503203605869554585,8,2004
The expanding scope of bioinformatics: sequence analysis and beyond,RB Altman,"Heredity 90 (5), 345",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15482673327289302544,8,2003
Missing value estimation,"OG Troyanskaya, D Botstein, RB Altman","A practical approach to microarray data analysis, 65-75",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5432040769365470776,8,2003
MHCWeb: converting a WWW database into a knowledge-based collaborative environment.,"L Hon, NF Abernethy, V Brusic, J Chai, RB Altman","Proceedings of the AMIA Symposium, 947",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17493793150131174952,8,1998
Ten grand challenges for medical informatics,RB Altman,Western Journal of Medicine,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13560386367951565520,8,1997
Data-driven human transcriptomic modules determined by independent component analysis,"W Zhou, RB Altman","BMC bioinformatics 19 (1), 327",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14558179199234318712,7,2018
Pharmacogenomics and big genomic data: from lab to clinic and back again,"A Lavertu, G McInnes, R Daneshjou, M Whirl-Carrillo, TE Klein, ...","Human molecular genetics 27 (R1), R72-R78",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11230659548120721302,7,2018
STAMS: STRING-assisted module search for genome wide association studies and application to autism,"S Hillenmeyer, LK Davis, ER Gamazon, EH Cook, NJ Cox, RB Altman","Bioinformatics 32 (24), 3815-3822",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2636252615534409536,7,2016
Using molecular features of Xenobiotics to predict hepatic gene expression response,"GH Fernald, RB Altman","Journal of chemical information and modeling 53 (10), 2765-2773",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8953594137396147928,7,2013
The state of the art in text mining and natural language processing for pharmacogenomics,"A Coulet, KB Cohen, RB Altman","Journal of Biomedical Informatics 45 (5), 825-826",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16640611558570182797,7,2012
Novel SNPs associated with warfarin dose in a large multicenter cohort of African Americans: Genome wide association study and replication results,"MA Perera, NA Limdi, L Cavallari, ER Gamazon, A Konkashbaev, ...","Circulation 124 (suppl_21), A15518-A15518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8309615672336355172,7,2011
Antiestrogen pathway (aromatase inhibitor),"Z Desta, A Nguyen, D Flockhart, T Skaar, R Fletcher, R Weinshilboum, ...","Pharmacogenetics and genomics 19 (7), 554",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11791896586861514420,7,2009
Proceedings of the Eighth International Conference on Intelligent Systems for Molecular Biology,"A Califano, G Stolovitzky, Y Tu, P Bourne, M Gribskov, R Altman",AAAI Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17204988249118341710,7,2000
The new peer review.,"IS Kohane, RB Altman","Proceedings of the AMIA Symposium, 433",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13832760132102440587,7,2000
Generating interactive molecular documentaries using a library of graphical actions,"P Pulavarthi, R Chiang, RB Altman","Biocomputing 2000, 266-277","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11348953741842020110,7154906308961723235",7,1999
Parallel hierarchical molecular structure estimation,"CC Chen, JP Singh, RB Altman",Supercomputing'96: Proceedings of the 1996 ACM/IEEE Conference on …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8162915460770428650,7,1996
Standardized biogeographic grouping system for annotating populations in pharmacogenetic research,"R Huddart, AE Fohner, M Whirl‐Carrillo, GL Wojcik, CR Gignoux, ...","Clinical Pharmacology & Therapeutics 105 (5), 1256-1262",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11144274740009505014,6,2019
The Pioglitazone trek via human PPAR gamma: From discovery to a medicine at the FDA and beyond,"PR Devchand, T Liu, RB Altman, GA FitzGerald, EE Schadt",Frontiers in pharmacology 9,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8460444046998018266,6,2018
Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome.,"EK Mallory, A Acharya, SE Rensi, PJ Turnbaugh, RA Bright, RB Altman","PSB, 56-67",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12285401006868506687,6,2018
PharmGKB summary: very important pharmacogene information for MT-RNR1,"JM Barbarino, TL McGregor, RB Altman, TE Klein","Pharmacogenetics and genomics 26 (12), 558",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11931705760291596756,6,2016
PharmGKB summary: very important pharmacogene information for SLC22A1,"S Goswami, L Gong, K Giacomini, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (6), 324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11118054548041237293,6,2014
BVS Integralidade em Saúde,"MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ...","Clin Pharmacol Ther 95 (2), 216-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6255182192129946733,6,2014
Biocomputing 2009,"RB Altman, AK Dunker, L Hunter",World Scientific,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15287980772472240023,12584876191379297615,16674154955268767803,2159796561208863256",6,2008
An XML‐based interchange format for genotype–phenotype data,"M Whirl‐Carrillo, M Woon, CF Thorn, TE Klein, RB Altman","Human mutation 29 (2), 212-219",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10882272815285016831,6,2008
An “omics” view of drug development,"RB Altman, DL Rubin, TE Klein","Drug development research 62 (2), 81-85",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18380208226757598256,6,2004
Edinburgh-Stanford TREC-2003 Genomics Track.,"M Osborne, M Cuminskey, G Sinclair, M Smillie, BL Webber, JT Chang, ...","TREC, 622-630",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4377802620935296311,6,2003
ViewFeature: integrated feature analysis and visualization,"DR Banatao, CC Huang, PC Babbitt, RB Altman, TE Klein","Biocomputing 2001, 240-250",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14100166072622831355,6,2000
Computational Modeling of Structured Experimental Data,"MA Bada, RB Altman",Methods in Enzymology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17029993795247576009,6,1999
Probabilistic constraint satisfaction: application to radiosurgery.,"RB Altman, R Tombropoulos","Proceedings of the Annual Symposium on Computer Application in Medical Care, 780",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5460119781921027,6,1994
Determination of the spatial distribution of protein structure using solution data,"RB Altman, BS Duncan, JF Brinkley, BG Buchanan, O Jardetzky",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16589454990432870350,6,1988
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression,"AT Amare, KO Schubert, F Tekola-Ayele, YH Hsu, K Sangkuhl, G Jenkins, ...","Journal of Neural Transmission 126 (1), 35-45",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17716771603310939993,5,2019
Shallow representation learning via Kernel PCA improves QSAR modelability,"SE Rensi, RB Altman","Journal of chemical information and modeling 57 (8), 1859-1867",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4366153554476358451,5,2017
"PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics","AE Fohner, A Sparreboom, RB Altman, TE Klein","Pharmacogenetics and genomics 27 (4), 164",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12010533563028842648,5,2017
Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system,"L Han, R Ball, CA Pamer, RB Altman, S Proestel","Journal of the American Medical Informatics Association 24 (5), 913-920",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13801990587913060415,5,2017
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response,"JM Biernacka, K Sangkuhl, G Jenkins, RM Whaley, P Barman, A Batzler, ...","Translational psychiatry 6 (11), e937",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13479160184710406852,5,2016
Enabling the curation of your pharmacogenetic study,"EM McDonagh, M Whirl‐Carrillo, RB Altman, TE Klein","Clinical Pharmacology & Therapeutics 97 (2), 116-119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11628036094065112351,5,2015
Training the next generation of quantitative biologists in the era of big data.,"KA Pattin, AC Greene, RB Altman, KB Cohen, E Wethington, C Görg, ...","Pacific Symposium on Biocomputing, 488-492",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10572719943149703274,5,2015
Inferring the semantic relationships of words within an ontology using random indexing: applications to pharmacogenomics,"B Percha, RB Altman","AMIA Annual Symposium Proceedings 2013, 1123",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14905095942973380688,5,2013
Structural insights into pre-translocation ribosome motions,"SC Flores, R Altman","Biocomputing 2011, 205-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2798936734041571189,5,2011
Text mining of the scientific literature to identify pharmacogenomic interactions,Y Garten,Stanford University,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8996162744053474085,5,2010
Current progress in Bioinformatics 2010,RB Altman,"Briefings in bioinformatics 11 (1), 1-2","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14641336141939460222,4841135053139668988",5,2010
Computational functional genomics,"MP Liang, OG Troyanskaya, A Laederach, DL Brutlag, RB Altman","IEEE Signal Processing Magazine 21 (6), 62-69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1325951787777730906,5,2004
A personalized and automated dbSNP surveillance system,"S Liu, S Lin, M Woon, TE Klein, RB Altman",Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13380044101589633058,5,2003
Complexities of managing biomedical information,RB Altman,"OMICS A Journal of Integrative Biology 7 (1), 127-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6631905785958253221,5,2003
Biomedical computation at Stanford University: a larger umbrella for the future.,RB Altman,"MD computing: computers in medical practice 17 (6), 35-37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16830235541864425556,5,2000
CLEAVER: Analyzing microarray data using known biological categories,"S Raychaudhuri, PD Sutphin, JM Stuart, RB Altman",SMI Rep,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10433053756862067516,5,2000
A surface measure for probabilistic structural computations.,"JP Schmidt, CC Chen, JL Cooper, RB Altman","ISMB, 148-156",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1726900232342862777,5,1998
Graphical style sheets: towards reusable representations of biomedical graphics,"RM Felciano, R Altman",Conference on Human Factors in Computing Systems: CHI 98 conference summary …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18199935222336716402,5,1998
Proclass protein family database: new version with motif alignments,"CH Wu, S Shivakumar","Pac Symp Biocomput, 719-730",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5856344173877479231,5,1998
Structural uncertainty of proteins in solution by NMR. A re-evaluation of the structure of the,"RB Altman, R Pachter, O Jardetzky","Applied Magnetic Resonance 4 (4), 441-460",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=913907110556399643,5,1993
NMR and protein structure,"O Jardentsky, R Altman, M Madrid",Magnetic resonance and related phenomena,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16110663718861451577,5,1989
A new method for the determination of protein structures in solution from NMR,"D Jardetzky, A Lane, JF Lefevre, E Lichtarge, B Hayes-Roth, R Altman, ...",Proceedings Twenty-Third Congress Ampere,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6708853971448051301,5,1986
"lyer, SB and Jardetzky, O.(1990)","CH Arrowsmith, R Pachter, RB Altman","Biochemistry 29, 6332-6341",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1181720038801856176,5,0
Systematic target function annotation of human transcription factors,"YF Li, RB Altman","BMC biology 16 (1), 4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6442416749562174386,4,2018
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans,"A Gottlieb, R Daneshjou, M DeGorter, S Bourgeois, PJ Svensson, ...","Genome medicine 9 (1), 98",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=986118472918245034,4,2017
PharmGKB summary: very important pharmacogene information for ABCG2,"AE Fohner, DJ Brackman, KM Giacomini, RB Altman, TE Klein","Pharmacogenetics and genomics 27 (11), 420",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=221445689498927894,4,2017
A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease,"L Han, M Maciejewski, C Brockel, W Gordon, SB Snapper, JR Korzenik, ...","Bioinformatics 34 (6), 985-993",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7067439776147515004,4,2017
"PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics","AE Fohner, EM McDonagh, JP Clancy, MW Carrillo, RB Altman, TE Klein","Pharmacogenetics and genomics 27 (1), 39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4105336553569457431,4,2017
PharmGKB summary: abacavir pathway,"JM Barbarino, DL Kroetz, RB Altman, TE Klein","Pharmacogenetics and genomics 24 (5), 276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7512637395486833246,4,2014
"PharmGKB summary: diuretics pathway, pharmacodynamics","CF Thorn, DH Ellison, ST Turner, RB Altman, TE Klein","Pharmacogenetics and genomics 23 (8), 449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17031061689173400265,4,2013
Contraception and prevention of HIV infection,W Cates,"JAMA 296 (23), 2802-2802",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8830400893385693503,4,2006
Pharmacogenomics: the relevance of emerging genotyping technologies,"T Hernandez-Boussard, TE Klein, RB Altman","MEDICAL LABORATORY OBSERVER 38 (3), 24",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11440759697680269618,4,2006
Protecting privacy of human subjects,PA Roche,"Science 307 (5713), 1200-1201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16030248788397747671,4,2005
Statistical analysis of protein structures,"L Wei, JT Chang, RB Altman","Computational Methods in Molecular Biology"" Eds. SL Salzberg, DB Searls & S …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=766273673310448850,4,1998
Determination of Large Protein Structures from NMR Data: Definition of the Solution Structure of the TRP Repressor,"RB Altman, CH Arrowsmith, R Pachter, O Jardetzky",Computational Aspects of the Study of Biological Macromolecules by Nuclear …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8883545890639793252,4,1991
Determination of Structural Uncertainty from NMR and Other Data: The ,"RB Altman, R Pachter, O Jardetzky","Protein Structure and Engineering, 79-95",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15942123809403179342,4,1989
A heuristic refinement method for spatial constraint satisfaction problems,"JF Brinkley, BG Buchanan, RB Altman, BS Duncan, C Cornelius",Stanford University,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8795245569407007150,4,1987
Effect of ,"E Danese, S Raimondi, M Montagnana, A Tagetti, T Langaee, P Borgiani, ...","Clinical Pharmacology & Therapeutics 105 (6), 1477-1491",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12946692936301502813,3,2019
Classifying Non-Small Cell Lung Cancer Histopathology Types and Transcriptomic Subtypes using Convolutional Neural Networks,"KH Yu, F Wang, GJ Berry, C Re, RB Altman, M Snyder, IS Kohane","bioRxiv, 530360",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8513276216893649427,3,2019
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development,"JL Wilson, R Racz, T Liu, O Adeniyi, J Sun, A Ramamoorthy, ...","PLoS computational biology 14 (12), e1006614",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10818300191365194613,3,2018
High precision protein functional site detection using 3D convolutional neural networks,"W Torng, RB Altman","Bioinformatics 35 (9), 1503-1512",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6301950727589909752,3,2018
Computational analysis of kinase inhibitor selectivity using structural knowledge,"YC Lo, T Liu, KM Morrissey, S Kakiuchi-Kiyota, AR Johnson, F Broccatelli, ...","Bioinformatics 35 (2), 235-242",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7463704031959243674,3,2018
"PharmGKB summary: clobazam pathway, pharmacokinetics","R Huddart, JS Leeder, RB Altman, TE Klein","Pharmacogenetics and genomics 28 (4), 110-115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6437593205303548348,3,2018
Biological and functional relevance of CASP predictions,"T Liu, S Ish‐Shalom, W Torng, A Lafita, C Bock, M Mort, DN Cooper, ...","Proteins: Structure, Function, and Bioinformatics 86, 374-386",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14215066729971181630,3,2018
"Biomarkers: Delivering on the expectation of molecularly driven, quantitative health","JL Wilson, RB Altman","Experimental Biology and Medicine 243 (3), 313-322",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14571971819322116564,3,2018
GeneDive: A gene interaction search and visualization tool to facilitate precision medicine.,"P Previde, B Thomas, M Wong, EK Mallory, D Petkovic, RB Altman, ...","PSB, 590-601",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4360141201351700106,3,2018
Estimation of maximum recommended therapeutic dose using predicted promiscuity and potency,"T Liu, T Oprea, O Ursu, C Hasselgren, RB Altman","Clinical and translational science 9 (6), 311-320",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2142807777852494947,3,2016
Population‐specific single‐nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans,"R Daneshjou, LH Cavallari, PE Weeke, KJ Karczewski, K Drozda, ...","Molecular genetics & genomic medicine 4 (5), 513-520",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3524330239900459137,3,2016
Potential adverse effects of anesthesia in children—reply,"BM Psaty, R Platt, RB Altman","Jama 314 (4), 409-409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15593627651691474627,3,2015
Translational bioinformatics,"JD Tenenbaum, NH Shah, RB Altman","Biomedical Informatics, 721-754",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15066125264386129683,3,2014
PharmGKB summary,"C Thorn, Y Ji, R Weinshilboum, R Altman, T Klein","Pharmacogenetics and Genomics 22 (8), 646-651",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17933091451402314657,3,2012
Interview by E,B Altman,Lefebvre,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15413015020631883492,3,2011
ERRATUM: Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels,"NP Tatonetti, JC Denny, SN Murphy, GH Fernald, G Krishnan, V Castro, ...",Clinical pharmacology and therapeutics 90 (3),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6091939361528603273,3,2011
"Estimation of the warfarin dose with clinical and pharmacogenetic data (vol 360, pg 753, 2009)","TE Klein, RB Altman, N Eriksson, BF Gage, SE Kimmel, MTM Lee, ...","New England Journal of Medicine 361 (16), 1613-1613",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6006292343524556890,3,2009
Current progress in bioinformatics 2007,RB Altman,"Briefings in bioinformatics 8 (5), 277-278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1940184844788401373,3,2007
BIOCOMPUTING 2017,"RB Altman, AK Dunker, L Hunter, MD Ritchie, T Murray, TE Klein",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3008063658719028692,3,2004
PharmGKB and pharmacological reviews,"DR Abernethy, R Altman, RM Long","Pharmacological reviews 55 (3), 397-397",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4988054377921141306,3,2003
Text analysis of scientific literature can automatically determine if a group of genes share a common biological function,"S Raychaudhuri, HS SchuÈtze, RB Altman","Genome Res 12 (10), 1582-1590",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1290762360030104892,3,2002
Knotted umbilical cord,"RB Altman, JE Merino","New England Journal of Medicine 334 (9), 573-573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17235045118325820117,3,1996
Pacific Symposium on Biocomputing'97,R Altman,"Pacific Symposium on Biocomputing 1997: Maui, Hawaii)","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5789356622025744201,14032246540187950936",3,1996
Computing the Structure of Large Complexes: Applying Constraint Satisfaction Techniques to Modeling the 16S Ribosomal RNA,"R Chen, D Fink, R Altman","Biomolecular NMR Spectroscopy, 279-299",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13383214840887435943,3,1995
Artificial intelligence techniques and NMR spectroscopy: Application to the structure of proteins in solution,"BS Duncan, JF Brinkley, RB Altman, BG Buchanan, O Jardetzky","NMR: Principles and Applications to Biomedical Research, 99-123",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8041382854760513933,3,1990
Elucidating protein structure from constraints in PROTEAN,"B Hayes-Roth, BG Buchanan, O Lichtarge, M Hewett, RB Altman, ...",Addison-Wesley,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12169811122965713707,3,1988
A Heuristic Refinement for Spacial Constraint Satisfaction Problems,"J Brinkley, B Buchanan, R Altman, B Duncan, C Cornelius",Stanford University,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=497759817073608258,3,1987
Predicting HLA class II antigen presentation through integrated deep learning,"B Chen, MS Khodadoust, N Olsson, LE Wagar, E Fast, CL Liu, ...","Nature biotechnology 37 (11), 1332-1343",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14191799044808638233,2,2019
Predicting venous thromboembolism risk from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges,"G McInnes, R Daneshjou, P Katsonis, O Lichtarge, RG Srinivasan, ...",Human mutation,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4538186684476428901,2,2019
"Reversals and limitations on high-intensity, life-sustaining treatments","G Chavez, IB Richman, R Kaimal, J Bentley, LA Yasukawa, RB Altman, ...","PloS one 13 (2), e0190569",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14796815297844140643,2,2018
Mendelian disease associations reveal novel insights into inflammatory bowel disease,"L Han, M Maciejewski, C Brockel, L Afzelius, RB Altman","Inflammatory bowel diseases 24 (3), 471-481",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17523918163650839135,2,2018
Challenges for training translational researchers in the era of ubiquitous data,RB Altman,"Clinical Pharmacology & Therapeutics 103 (2), 171-173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5602364862487525773,2,2018
Pharmacogenomics Clinical Annotation Tool (PharmCAT),"K Sangkuhl, M Whirl‐Carrillo, RM Whaley, M Woon, A Lavertu, RB Altman, ...",Clinical Pharmacology & Therapeutics,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14975555224668980773,2,2018
Maria: accurate prediction of MHC-II peptide presentation with deep-learning and lymphoma patient MHC-II ligandome,"B Chen, M Khodadoust, N Olsson, E Fast, LE Wagar, CL Liu, M Davis, ...","Blood 130 (Suppl 1), 1486-1486",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17386244431646407895,2,2017
"PharmGKB summary: pazopanib pathway, pharmacokinetics","CF Thorn, MR Sharma, RB Altman, TE Klein","Pharmacogenetics and genomics 27 (8), 307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3517379397584300993,2,2017
Flexible analog search with kernel PCA embedded molecule vectors,"S Rensi, RB Altman","Computational and structural biotechnology journal 15, 320-327",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3900448406834362792,2,2017
Towards Clinical Bioinformatics: Redux 2015,RB Altman,"Yearbook of medical informatics 25 (S 01), S6-S7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9168707404478495457,2,2016
PharmGKB summary: very important pharmacogene information for CFTR,"EM McDonagh, JP Clancy, RB Altman, TE Klein","Pharmacogenetics and genomics 25 (3), 149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8752410893863409297,2,2015
Building the next generation of quantitative biologists,"KA Pattin, AC Greene, RB Altman, LE Hunter, DA Ross, JA Foster, ...","Biocomputing 2014, 417-421",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7414648130206248116,2,2014
Using surface envelopes to constrain molecular modeling,"JM Dugan, RB Altman","Protein science 16 (7), 1266-1273",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14424217330761176107,2,2007
"The incidentalome: A threat to genomic medicine (vol 296, pg 212, 2006)",IS Kohane,"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 296 (12), 1466-1466",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1474819205609687138,2,2006
The SimTK framework for physics-based simulation of biological structures: preliminary design,"MA Sherman, JL Middleton, JP Schmidt, DS Paik, SS Blemker, AW Habib, ...",Proceedings of the Workshop on Component Models and Frameworks in High …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9422232514503660826,2,2005
Approaches for protecting privacy in the genomic era,"Z Lin, AB Owen, RB Altman","Genetic Engineering News 24 (17), 6-+",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9382618022505113359,2,2004
Edinburgh-stanford TREC 2003 genomics track: Notebook paper,"M Osborne, J Chang, M Cumiskey, N Mehra, V Rotemberg, G Sinclair, ...",Proceedings of the Twelfth Text REtrieval Conference,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2784715711178990384,2,2003
Scoring functions sensitive to alignment error have a more difficult search: A paradox for threading,"J Chang, MW Carrillo, A Waugh, L Wei, RB Altman",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12340449095562550669,2,2002
Challenges for knowledge discovery in biology,R Altman,Proceedings of the seventh ACM SIGKDD international conference on Knowledge …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17892549983898146393,2,2001
Application of supervised machine learning to identify genes associated with the hypoxia response,"PD Sutphin, S Raychaudhuri, NC Denko, RB Altman, AJ Giaccia","Nature Genetics 27 (4s), 90",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6682666155722238276,2,2001
"Management of data, knowledge, and metadata on the semantic web: Experience with a pharmacogenetics knowledge base","DE Oliver, M Hewett, DL Rubin, JM Stuart, TE Klein, RB Altman","Stanford Medical Informatics Research Reports SMI-2001–0901–1, 9th September …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10456690943165678555,2,2001
Probabilistic constraint network representation of biological structure,RB Altman,"Mathematical Methods in Medical Imaging III 2299, 218-228",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=935623062769806333,2,1994
A deep learning framework to predict binding preference of RNA constituents on protein surface,"JH Lam, Y Li, L Zhu, R Umarov, H Jiang, A Héliou, FK Sheong, T Liu, ...","Nature communications 10 (1), 1-13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14519562385735199300,1,2019
Graph Convolutional Neural Networks for Predicting Drug-Target Interactions,"W Torng, RB Altman","Journal of Chemical Information and Modeling 59 (10), 4131-4149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12684224135818528021,1,2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients,"JP Lewis, JD Backman, JL Reny, TO Bergmeijer, BD Mitchell, MD Ritchie, ...",European Heart Journal-Cardiovascular Pharmacotherapy,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3365796592965754247,1,2019
Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site,"YC Lo, O Cormier, T Liu, KW Nettles, JA Katzenellenbogen, T Stearns, ...","Nature communications 10 (1), 1033",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7421319917084411858,1,2019
# Science: The potential and the challenges of utilizing social media and other electronic communication platforms in health care,"V Gijsen, M Maddux, A Lavertu, G Gonzalez‐Hernandez, N Ram, ...",Clinical and Translational Science,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17848340817833596418,1,2019
A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases,"DN Sosa, A Derry, M Guo, E Wei, C Brinton, RB Altman","bioRxiv, 727925",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12627024245155174693,1,2019
Hubble2D6: a deep learning approach for predicting drug metabolic activity,"G McInnes, R Dalton, K Sangkuhl, M Whirl-Carrillo, S Lee, RB Altman, ...","BioRxiv, 684357",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8368093159519453150,1,2019
Essential Characteristics of Pharmacogenomics Study Publications,"CF Thorn, M Whirl‐Carrillo, H Hachad, JA Johnson, EM McDonagh, ...","Clinical Pharmacology & Therapeutics 105 (1), 86-91",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6999864448917521062,1,2019
"PharmGKB summary: oxycodone pathway, pharmacokinetics","R Huddart, M Clarke, RB Altman, TE Klein","Pharmacogenetics and genomics 28 (10), 230-237",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9121292898651703645,1,2018
"PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics","M Alvarellos, C Guillemette, RB Altman, TE Klein","Pharmacogenetics and genomics 28 (5), 127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18029081981204541206,1,2018
PharmGKB summary,"J Barbarino, AO Obeng, T Klein, R Altman","Pharmacogenetics and Genomics 27 (5), 201-209",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2735652027034325371,1,2017
Population-specific imputation of gene expression improves prediction of pharmacogenomic traits for African Americans,"A Gottlieb, R Daneshjou, M DeGorter, S Montgomery, R Altman","BioRxiv, 115451",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=44499798878390847,1,2017
Application of new informatics tools for identifying allosteric lead ligands of the c-Src kinase,"LX Peng, M Lawrenz, D Shukla, GW Tang, VS Pande, RB Altman","BioRxiv, 038323",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13346860358453801843,1,2016
Current Progress in Bioinformatics 2016,R Altman,"Briefings in bioinformatics 17 (1), 1-1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14010705723739390429,1,2016
Separating the causes and consequences in disease transcriptome,"YF Li, F Xin, RB Altman","Biocomputing 2016: Proceedings of the Pacific Symposium, 381-392",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17779518181039750980,1,2016
Corrigendum: Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways,"KJ Kohlhoff, D Shukla, M Lawrenz, GR Bowman, DE Konerding, D Belov, ...","Nature chemistry 7 (9), 759",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11520054277618123818,1,2015
PharmGKB summary,"E McDonagh, J Lau, M Alvarellos, R Altman, T Klein","Pharmacogenetics and Genomics 25 (7), 363-376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13484817716767428338,1,2015
Genomics in the clinic: ethical and policy challenges in clinical next-generation sequencing programs at early adopter USA institutions,"LC Milner, NA Garrison, MK Cho, RB Altman, L Hudgins, SJ Galli, ...","Personalized medicine 12 (3), 269-282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5493837992775087277,1,2015
Distribute AI benefits fairly,R Altman,"Nature 521 (7553), 417-418",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10375620679907160024,1,2015
Response to ‘Use of an algorithm for identifying hidden drug—drug interactions in adverse event reports’ by Gooden ,"NP Tatonetti, JC Denny, RB Altman","Journal of the American Medical Informatics Association 20 (3), 591-591",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15263974820049098436,1,2013
Methods for building and refining 3D models of RNA,"SC Flores, M Jonikas, C Bruns, JP Ku, J Schmidt, RB Altman","RNA 3D Structure Analysis and Prediction, 143-166",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3403495684479314605,1,2012
702: Comprehensive maternal-fetal pharmacogenomics–a novel pharmacogenomic thumbprint,"Y Blumenfeld, C Fan, K Sangkuhl, R Altman, Y El-Sayed, S Quake","American Journal of Obstetrics & Gynecology 201 (6), S254",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18150088835536453572,1,2009
A general framework for dose optimization,"RG Turcott, H Sagreiya, EA Ashley, RB Altman, AK Das","AMIA Annual Symposium Proceedings 2009, 656",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3924041406832467898,1,2009
Qualitative Knowledge Models in,"M Peleg, IS Gabashvili, RB Altman","Genomics and Proteomics Engineering in Medicine and Biology 24, 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9816205073221333848,1,2006
Annual progress in bioinformatics 2006,RB Altman,"Briefings in Bioinformatics 7 (3), 209-210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=607656064655172847,1,2006
Correction: Time to organize the bioinformatics resourceome,"N Cannata, E Merelli, RB Altman","PLoS computational biology 2 (2), e20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7296054185061002739,1,2006
Health-Information Altruists,"IS Kohane, RB Altman",The New England Journal of Medicine 354 (5),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5414921060699350933,1,2006
Introduction to ontologies in biomedicine: from powertools to assistants,RB Altman,"Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10845282789440951694,1,2004
Pharmacokinetics of oral gallium maltolate administered in a single or multiple dose schedule in patients with Paget's disease of bone or primary hyperparathyroidism: A pilot …,"BL Lum, A Gottlieb, R Altman, PH Sayre, F Valone, F Iovine, N Dal Canto, ...","JOURNAL OF BONE AND MINERAL RESEARCH 18, S391-S391",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9038848771413976556,1,2003
Computer Applications in Molecular Biology,RB Altman,,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15686327004727724119,1,2003
Inducing Novel Gene-Drug Interactions from the Biomedical Literature,"SD Kamvar, DE Oliver, CD Manning, RB Altman","Bioinformatics 1 (1), 1-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18041244366464237951,1,2003
"Biocomputing 2003: Proceedings of the Pacific Symposium, Kauai, Hawaii, 3-7 January 2003",RB Altman,World Scientific,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9135553564321950283,1,2002
Predicting protein binding sites,"FE Boas, R Altman",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3179724426734457648,1,2000
The incidentalome,"IS Kohane, DR Masys, RB Altman","a threat to genomic medicine 2006, 296",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6030287347018048847,1,0
Fundamental tensions between genomic research and human subject privacy,"Z Lin, AB Owen, RB Altman","Technical Report SMI-2003 1009, 21",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10896057206807931307,1,0
PGxMine: Text mining for curation of PharmGKB,"J Lever, JM Barbarino, L Gong, R Huddart, K Sangkuhl, R Whaley, ...","Pacific Symposium on Biocomputing 25, 611-622",,0,2020
Maria-I: A Deep-Learning Approach for Accurate Prediction of MHC Class I Tumor Neoantigen Presentation,"KR Kathuria, B Chen, MS Khodadoust, N Olsson, MM Davis, JE Elias, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis,"L Han, M Askari, RB Altman, SK Schmitt, J Fan, JP Bentley, SM Narayan, ...","Circulation: Cardiovascular Quality and Outcomes 12 (10), e005595",,0,2019
Examining the Use of Real‐World Evidence in the Regulatory Process,"BK Beaulieu‐Jones, S Finlayson, W Yuan, RB Altman, IS Kohane, ...",Clinical Pharmacology & Therapeutics,,0,2019
"PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics","T Stevens, K Sangkuhl, JT Brown, RB Altman, TE Klein","Pharmacogenetics and genomics 29 (6), 136-154",,0,2019
Signal detection algorithms to identify drug effects and drug interactions,"N Tatonetti, RB Altman, GH Fernald","US Patent 10,354,202",,0,2019
"PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics","R Huddart, RB Altman, TE Klein","Pharmacogenetics and genomics 29 (4), 91-97",,0,2019
PathFXweb: a web application for identifying drug safety and efficacy phenotypes,"JL Wilson, M Wong, A Chalke, N Stepanov, D Petkovic, RB Altman",Bioinformatics,,0,2019
"Research Projects Supported by the University of California, San Francisco‐Stanford Center of Excellence in Regulatory Science and Innovation","K Giacomini, L Lin, R Altman","Clinical Pharmacology & Therapeutics 105 (4), 815-818",,0,2019
Pharmacogenomics in Dermatology: Tools for understanding gene-drug associations,"R Daneshjou, R Huddart, T Klein, R Altman","Seminars in cutaneous medicine and surgery 38 (1), E19",,0,2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteins,"DW Morgens, C Chan, AJ Kane, NR Weir, A Li, MM Dubreuil, CK Tsui, ...",eLife 8,,0,2019
Deep functional synthesis: a machine learning approach to gene functional enrichment,"S Wang, J Ma, S Fong, S Rensi, J Han, J Peng, D Pratt, RB Altman, ...","bioRxiv, 824086",,0,2019
Sex-specific genetic effects across biomarkers,"E Flynn, Y Tanigawa, F Rodriguez, RB Altman, N Sinnott-Armstrong, ...","bioRxiv, 837021",,0,2019
Unifying single-cell annotations based on the Cell Ontology,"S Wang, AO Pisco, J Karkanias, RB Altman","bioRxiv, 810234",,0,2019
Pathway and network embedding methods for prioritizing psychiatric drugs,"Y Pershad, M Guo, RB Altman","bioRxiv, 728055",,0,2019
RedMed: Extending drug lexicons for social media applications,"A Lavertu, RB Altman","bioRxiv, 663625",,0,2019
GRep: Gene Set Representation via Gaussian Embedding,"E Flynn, R Altman","bioRxiv, 519033",,0,2019
PharmGKB summary,"C Thorn, D Müller, R Altman, T Klein","Pharmacogenetics and Genomics 28 (9), 214-222",,0,2018
"PharmGKB summary: clozapine pathway, pharmacokinetics","CF Thorn, DJ Müller, RB Altman, TE Klein","Pharmacogenetics and genomics 28 (9), 214-222",,0,2018
"PharmGKB summary: voriconazole pathway, pharmacokinetics (vol 27, pg 201, 2017)","JM Barbarino, OA Owusu, TE Klein, RB Altman","PHARMACOGENETICS AND GENOMICS 28 (8), 198-198",,0,2018
Biocomputing 2019: Proceedings of the Pacific Symposium: Pacific Symposium on Biocomputing 2019,"RB Altman, AK Dunker, L Hunter, MD Ritchie, T Murray, TE Klein",World Scientific Publishing Co.,,0,2018
A E2F4/p107 complex regulates LDHA in the mechanism of chemotherapy resistance in human colorectal cancer stem cells,"J Matsubara, YF Li, P Dalerba, D Sahoo, RB Altman, MF Clarke","CANCER SCIENCE 109, 426-426",,0,2018
PharmGKB summary,"C Thorn, M Sharma, R Altman, T Klein","Pharmacogenetics and Genomics 27 (8), 307-312",,0,2017
E2F4/p107 complex regulates chemotherapy resistance in human colorectal cancer stem cells,"J Matsubara, YF Li, P Dalerba, D Sahoo, T Isobe, RB Altman, MF Clarke","Cancer Research 77 (13 Supplement), 81-81",,0,2017
"Running title: Functional assessment on CASP predictions Biological and Functional Relevance of CASP Predictions Tianyun Liu 1a, Shirbi Ish-Shalom 2a, Wen Torng 1a, Aleix …","SD Mooney, RB Altman",,,0,2017
2017 Reviewer Acknowledgement,"A Aggarwal, GA Aguirre, N Akamatsu, AM Alkhunaizi, M Arai, G Baffy, ...","Journal of Clinical and Translational Hepatology 5, 416-417",,0,2017
Exploring the Heritability of Pharmacogene Expression,"SL Mitchell, ER Gamazon, SP Hillenmeyer, RB Altman, NJ Cox, LK Davis","GENETIC EPIDEMIOLOGY 40 (7), 653-653",,0,2016
NATIONALITY: USA LICENSURE,RB Altman,,,0,2016
A Roadmap for Regulatory Science Research for Next Generation Sequencing Informatics,"JM Zook, ML Salit, RB Altman, A Sidow, R Goldfeder, E Ashley, ...",Science Translational Medicine 8 (Science Translational Medicine),,0,2016
Response to Open Peer Commentaries on “Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework”,"NH Evitt, S Mascharak, RB Altman",,,0,2016
Unmet needs,"R Altman, N Khuri, M Salit, K Giacomini",Science Translational Medicine 7 (315),,0,2015
"Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways (vol 6, pg 15, 2014)","KJ Kohlhoff, D Shukla, M Lawrenz, GR Bowman, DE Konerding, D Belov, ...",NATURE CHEMISTRY 7 (9),,0,2015
PharmGKB summary: peginterferon-α pathway,"SR Shuldiner, L Gong, AJ Muir, RB Altman, TE Klein","Pharmacogenetics and genomics 25 (9), 465",,0,2015
INTERACTIVE GENOTYPE-BASED DOSING GUIDELINES: PII-006,"M Whirl-Carrillo, R Whaley, K Caudle, M Relling, R Altman, T Klein",Clinical Pharmacology & Therapeutics 97,,0,2015
IN THE sPOTLIGHT Predicting Cancer Drug Response: Advancing the DREAM,RB Altman,,,0,2015
Genome Medicine,"A Patwardhan, J Harris, N Leng, G Bartha, DM Church, S Luo, ...",,,0,2015
Dear Dr. Altman and Members of the Science Board: The American Society of Anesthesiologists and the Society for Pediatric Anesthesia appreciate the opportunity to provide …,"RB Altman, DF Officer",,,0,2014
"Variation in the Binding Pocket of an Inhibitor of the Bacterial Division Protein FtsZ Across Genotypes, Nucleotide States, and Species","AV Miguel, J Hsin, T Liu, G Tang, RB Altman, KC Huang","Biophysical Journal 106 (2), 474a-475a",,0,2014
Investigating Ligand-Modulation of GPCR Activation Pathways,"M Lawrenz, K Kohlhoff, D Shukla, G Bowman, R Altman, V Pande","Biophysical Journal 106 (2), 14a",,0,2014
Biocomputing 2015: Proceedings of the Pacific Symposium,TA Murray,World Scientific Publishing Company,,0,2014
A TWENTIETH ANNIVERSARY TRIBUTE TO PSB,"D Hewett, M WHIRL-CARRILLO, LE Hunter, RB Altman, TE Klein","Pacific Symposium on Biocomputing Co-Chairs, 1-7",,0,2014
PharmGKB summary,"C Thorn, D Ellison, S Turner, R Altman, T Klein","Pharmacogenetics and Genomics 23 (8), 449-453",,0,2013
Fragment binding prediction using unsupervised learning of ligand substructure binding sites,"G Tang, R Altman",,,0,2013
2013–2014 ASCPT Board of Directors,"R Altman, J Wagner, K Giacomini, G Kearns, A Gaedigk, D Gupta, ...",Clinical Pharmacology & Therapeutics 94 (1),,0,2013
"Stanford Magnetic Resonance Laboratory, Stanford University Medical Center","RB Altman, R Pachter, O Jardetzky","Protein Structure and Engineering 183, 79",,0,2013
Expression Quantitative Trait Loci Analysis of Stable Warfarin Dose Identifies Novel Associations: Finding Signal within the Noise,"ER Gamazon, R Daneshjou, LH Cavallari, NA Limdi, M Wadelius, ...","Clinical Pharmacology and Therapeutics 93 (S1), S27-S27",,0,2013
Expanding the Autism Ontology to DSM-IV Criteria.,"O Mugzach, M Peleg, SC Bagley, RB Altman",AMIA,,0,2013
Personal omics profiling reveals dynamic molecular and medical phenotypes,"JF Ferguson, R Chen, GI Mias, J Li-Pook-Than, L Jiang, HY Lam, ...","Circulation: Cardiovascular Genetics 5 (3), 381-382",,0,2012
ASCPT NewS,"R Altman, WB Abrams","Clinical Pharmacology & Therapeutics 91 (6), 957",,0,2012
"Pacific Symposium on Biocomputing: Kohala Coast, Hawaii, USA, 3-7 January 2012",RB Altman,World Scientific Publishing Company,,0,2012
Systems Pharmacogenomics-Bridging the Gap.,"MD Ritchie, NJ Cox, C Cheng, S Weiss, TE Klein, RB Altman","Pacific Symposium on Biocomputing, 442",,0,2012
9789814366496: Proceedings of the Pacific Symposium,"RB Altman, AK Dunker, L Hunter, TA Murray, TE Klein",World Scientific Publishing Company,,0,2011
2011 Index IEEE/ACM Transactions on Computational Biology and Bioinformatics Vol. 8,"C Abdul-Wahid, S Abdul-Wahid, A Aberer, L Acharya, A Agrawal, ...","IEEE/ACM Transactions on Computational Biology and Bioinformatics 8 (6), 1",,0,2011
"Bourgine, Joanna; Garat, Anne; Allorge, Delphine; Crunelle-Thibaut, Aurélie; Lo-Guidice, Jean-Marc; Colombel, Jean-Frédéric; Broly, Franck; Billaut-Laden, Ingrid","L Ekström, JJ Schulze, C Guillemette, A Belanger, A Rane, ET Price, ...","Pharmacogenetics and Genomics 21 (6), 313-324",,0,2011
NIH revamp: real issue is resources,R Altman,"Nature 473 (7345), 31",,0,2011
Coarse-Grained Structural Modeling of Molecular Motors,DW Parker,Stanford University,,0,2011
Novel Approaches to the Visualization of Cell Specific Gene Expression Patterns,CBO Oyolu,Stanford University,,0,2011
A new disease-specific machine learning approach for the prediction of cancer-causing SNPs,"E Capriotti, RB Altman",F1000Research 1,,0,2010
"Nilesh J Samani, Maciej Tomaszewski and Heribert Schunkert c","EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ...",The Lancet 375 (9725),,0,2010
Evaluating Warfarin Pharmacogenetic Algorithms Via an Analysis of Factors Involved in Its Dosing and Stability,"H Sagreiya, C Berube, A Wen, R Ramakrishnan, A Mir, A Hamilton, ...","JOURNAL OF THROMBOSIS AND THROMBOLYSIS 29 (2), 259-259",,0,2010
Pacific Symposium on Biocomputing 2011 (BIOCOMPUTING 2011),"RB Altman, AK Dunker, L Hunter, T Murray, TE Klein",,,0,2010
Thiopurine pathway,"Z Gianluigi, C Meyling, K Natalia, T Caroline, G Stocco, JM Hebert, ...",,,0,2010
Markov State Models for Protein and RNA Folding,GR Bowman,Stanford University,,0,2010
Proceedings of the Pacific Symposium on Biocomputing 2011,RB Altman,World Scientific Publishing Company Pte Limited,,0,2010
"Our thanks to all those who have helped with this issue of Pharmacogenomics. Listed below are authors, referees and others who have kindly given their time, effort and …","A Adeyemo, I Ahmad, M Alda, RB Altman, S Basic, E Berns, M Bijl, ...",Pharmacogenomics 11 (10),,0,2010
Pacific Symposium on Biocomputing 2010,"AK Dunker, L Hunter, TE Klein, MD Ritchie",World Scientific,,0,2009
"Medicine."" Departments of Bioengineering and Genetics.” The Howard Hughes Medical Institute.” Department of Pediatrics","RB ALTMAN, MM DAVIS, AJ BUTTE","Biocomputing 2009-Proceedings Of The Pacific Symposium, 439",,0,2008
Text mining for pharmacogenomics,RB Altman,Proceedings of the 2nd international workshop on Data and text mining in …,,0,2008
2008 Index IEEE/ACM Transactions on Computational Biology and Bioinformatics Vol. 5,"Y Admanit, T Aittokallio, RB Altman, S Aluru, JC Aman, C Bailey-Kellogg, ...","IEEE/ACM Transactions on Computational Biology and Bioinformatics 5 (4), 1",,0,2008
COMPUTATIONAL SYSTEMS BIOLOGY,"A Funahashi, Y Matsuoka, A Jouraku, M Morohashi, N Kikuchi, H Kitano, ...",Proceedings of the IEEE 96 (8),,0,2008
'We are also in the midst of an effort to catalog all known human genomic variations that have been reported to have an affect on drug response-we think there are hundreds of …,"RB Altman, S Nanda","PHARMACOGENOMICS 9 (6), 663-665",,0,2008
"Pacific Symposium on Biocomputing 2008: Kohala Coast, Hawaii, USA, 4-8 January 2008",R Altman,World Scientific,,0,2008
Commentaries on,"RB Altman, R Balling, F Martin-Sanchez, GI Mihalas, Y Shahar, ...",,,0,2008
Combining simulation and machine learning to recognize function in 4D,RB Altman,2007 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …,,0,2007
Ontological issues in pharmacogenomics,RB Altman,"The Monist 90 (4), 523-533",,0,2007
The international society for computational biology 10th anniversary,"L Hunter, RB Altman, PE Bourne","PLoS computational biology 3 (6), e135",,0,2007
Genetic nondiscrimination legislation,"R Altman, N Benowitz, D Gurwitz, J Lunshof, M Relling, J Lamba, ...",Pharmacogenomics 8 (5),,0,2007
"Distinct contribution of electrostatics, initial conformational ensemble and macromolecular stability in RNA folding","M Brenowitz, A Laederach, I Shcherbakova, M Jonikas, RB Altman",ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 233,,0,2007
Pharmacogenetics/Pharmacogenomics,"XJ Lou, RB Altman, TE Klein","Bioinformatics‐From Genomes to Therapies, 1427-1455",,0,2007
"Biocomputing 2008: Proceedings of the Pacific Symposium, Kohala Coast, Hawaii, USA, 4-8 January 2008","RB Altman, AK Dunker, L Hunter",World Scientific,,0,2007
PharmGED: Pharmacogenetic effect database. Commentary,"AE HODGE, RB ALTMAN, TE KLEIN, B XIE, CJ ZHENG, LY HAN, S ONG, ...",Clinical pharmacology and therapeutics 81 (1),,0,2007
Available online at www. sciencedirect. com,"A Abu-Hanna, S Alayón, R Alonso-Calvo, RB Altman, JS Ancker, N Arora, ...","Journal of Biomedical Informatics 40, 803-804",,0,2007
The Incidentalome—Reply,"IS Kohane, DR Masys, RB Altman","JAMA 296 (23), 2800-2802",,0,2006
PharmGKB: Capturing knowledge to catalyze pharmacogenomics research,R Altman,"Nature Precedings, 1-1",,0,2006
L'incidentalome: Une menace pour la medecine genomique,"IS Kohane, DR Masys, RB Altman","JAMA-français 296 (2), 212",,0,2006
Physics-based simulation of biological structures,"SL Delp, FC Anderson, RB Altman","3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro, 2006 …",,0,2006
Delivering diverse data to multiple audiences: the PharmGKB model,RB Altman,"The Scientist 20 (4), 49-51",,0,2006
Pacific symposium on biocomputing 2006,"RB Altman, A Dunker, L Hunter, TE Klein",Unknown Journal,,0,2006
Challenges in Creating an Infrastructure for Physics-Based Simulation of Biological Structures.,RB Altman,"CSB, 3",,0,2005
"A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge (vol 12, pg 121, 2005)","DL Rubin, CF Thorn, TE Klein, RB Altman","JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION 12 (3), 364-364",,0,2005
Annual progress in bioinformatics,RB Altman,"Briefings in Bioinformatics 6 (1), 4-5",,0,2005
Protecting privacy of human subjects-Response,"RB Altman, Z Lin, AB Owen","SCIENCE 307 (5713), 1201-1201",,0,2005
Frontiers of Bioinformatics: Unsolved Problems and Challenges,"S Karlin, DS Eisenberg, R Altman",National Academies Press,,0,2005
SOUNDING BOARD-Health-Information Altruists,"IS Kohane, RB Altman","New England Journal of Medicine 353 (19), 2074-2077",,0,2005
"Pacific Symposium on Biocomputing 2005: Hawaii, USA, 4-8 January 2005","R Altman, AK Dunker, L Hunter",World Scientific,,0,2004
PharmGKB: The Pharmacogenetics and Pharmacogenomic Knowledge Base,RB Altman,"DRUG METABOLISM REVIEWS 36, 14-14",,0,2004
Methods and Resources-Resource-Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery,"I Yeh, T Hanekamp, S Tsoka, PD Karp, RB Altman","Genome Research 14 (5), 917-924",,0,2004
Towards Clinical Bioinformatics,RB Altman,"Yearbook of medical informatics 13 (01), 1-2",,0,2004
Automatic construction of 3D structural motifs for protein function prediction,"MP Liang, DL Brutlag, RB Altman",Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE …,,0,2003
"Pacific Symposium on Biocomputing'99, World Scientific, New Jersey; Pacific Symposium on Biocomputing'00, World Scientific, New Jersey; Pacific Symposium on Biocomputing'01 …","RB Altman, AK Dunker, L Hunter, TE Klein, K Lauderdale","Washington State University, Pullman WA",,0,2003
Mining heterogeneous ribosomal structure data,"IS Gabashvili, M Whirl-Carrillo, M Bada, DR Banatao, RB Altman","BIOPHYSICAL JOURNAL 84 (2), 463A-463A",,0,2003
Methods and Resources-Methods-Identification of Promoter Regions in the Human Genome by Using a Retroviral Plasmid Library-Based Functional Reporter Gene Assay,"S Khambata-Ford, Y Liu, C Gleason, M Dickson, RB Altman, S Batzoglou, ...","Genome Research 13 (7), 1765-1774",,0,2003
Special Paper-Introduction.,"RB Altman, AK Dunker, L Hunter, TE Klein","Pacific Symposium on Biocomputing, 636-637",,0,2003
ISMB 2002,"J Glasgow, B Rost","ISMB, 1-4",,0,2002
Erratum: Diversity of gene expression in adenocarcinoma of the lung (Proceedings of the National Academy of Sciences of the United States of America (2001) 98 (13784-13789)),"ME Garber, OG Troyanskaya, K Schluens, S Petersen, Z Thaesler, ...",Proceedings of the National Academy of Sciences of the United States of …,,0,2002
Use of Children as Interpreters,RB Altman,"Science 298, 2345-2349",,0,2002
"Pacific Symposium on Biocomputing 2003: Kauai, Hawaii, 3-7 January 2003","RB Altman, AK Dunker, L Hunter",World Scientific,,0,2002
Modeling molecular function and failure: Misreading of genetic code by the ribosome,"IS Gabashvili, M Peleg, RB Altman","BIOPHYSICAL JOURNAL 82 (1), 167A-168A",,0,2002
MYCOBACTERIOLOGY AND AEROBIC ACTINOMYCETES-Determining the Genomic Locations of Repetitive DNA Sequences with a Whole-Genome Microarray: IS6110 in Mycobacterium tuberculosis,"M Kivi, X Liu, S Raychaudhuri, RB Altman, PM Small","Journal of Clinical Microbiology 40 (6), 2192-2198",,0,2002
An ontology tool for query formulation in an agent-based context.,"DP Southall, S Burr, RD Smith, DN Bull, A Randford, A Williams, ...","Information Technology Journal 1 (2), 1054-1064",,0,2000
Structured representations of biological data: from ribosomes to pharmacogenetics,RB ALTMAN,9^< th> Bioinformatics and genome research,,0,2000
"Biocomputing 2001: Proceedings of the Pacific Symposium, Mauna Lani, Hawaii, 3-7 January 2001","RB Altman, AK Dunker, L Hunker, K Lauderdale, TE Klein",World Scientific Publishing Company,,0,2000
"COLUMNS-The LabNet-Biomedical Computation at Stanford University: A Larger Umbrella for the Future-Integrating the efforts of medicine, biology, computing and engineering will …",RB Altman,"MD Computing 17 (6), 15-18",,0,2000
"Pacific Symposium on Biocomputing'99: Mauna Lani, Hawaii, USA, 4-9 January 1999","RB Altman, Pacific Symposium on Biocomputing",World Scientific,,0,1999
"Other Current articles of Interest to readers of this issue-Research Papers-Are predicted structures good enough to preserve functional sites? by Liping Wei, Enouch S Huang and …","L Wei, ES Huang, RB Altman","Current Opinion in Structural Biology 9 (4), 643-662",,0,1999
Section X Bioinformatics and Molecular Applications-Bioinformatics and Query Generation-MHCWeb: Converting a WWW Database into a Knowledge-Based Collaborative Environment,"L Hon, NF Abernethy, V Brusic, J Chai, RB Altman","Journal of the American Medical Informatics Association, 947-951",,0,1998
Section VIII Standards and Policies-Standards for Clinical Data-Updating a Bibliography Using the Related Articles Function within PubMed,"X Liu, RB Altman","Journal of the American Medical Informatics Association, 750-754",,0,1998
Computing the Structure of Large Complexes: Modeling the 16S Ribosomai,"R Chen, D Fink, RB Altman","Biological NMR Spectroscopy, 247",,0,1997
Biocomputing'98: Proceedings of the Pacific Symposium,"RB Altman, AK Dunker, L Hunter, TE Klein","Biocomputing'98: Proceedings of the Pacific Symposium, 1-784",,0,1997
Pacific symposium on biocomputing97: Proceedings,"RB Altman, AK Dunker, L Hunter, TE Klein","World Scientific Publishing Co. Pte. Ltd., River Edge, NJ (United States)",,0,1996
ISMB-95--Third international conference on intelligent systems for molecular biology: Proceedings,"C Rawlings, D Clark, R Altman, L Hunter, T Lengauer, S Wodak","Stanford Univ., CA (United States)",,0,1995
Biocomputing'96-Proceedings Of The Pacific Symposium,H Lawrence,World Scientific,,0,1995
THE EVOLUTION OF BIOMOLECULAR STRUCTURES AND THE STRUCTURE OF BIOMOLECULAR EVOLUTION,"RA GOLDSTEIN, RB ALTMAN","Ann Arbor 1001, 48109-1055",,0,1995
A Formal Evaluation of the TransF ER Model for Bridging Heterogeneous Databases,W Sujansky,,,0,1995
A library of low-variance cores for protein families,"RB Altman, R Schmidt, M Gerstein","BIOCOMPUTING'96 17, 703",,0,1994
STRUCTURES FROM NMR DATA,"RB Altman, CH Arrowsmith, R Pachter, O Jardetzky",Computational Aspects of the Study of Biological Macromolecules by Nuclear …,,0,1991
MANUFACTURING,J LYMAN,"ELECTRONICS 59 (33), 105-106",,0,1986
Prospective Evaluation of Treatment in Patients with Polymyositis and Dermatomyositis,"C Clark, T Bertorini, H Neville, R Miller, A Bender, M Rivner, R Bennett, ...",Neurology 36 (4),,0,1986
New Strategies for the Determination of Macromolecular Structure in Solution123,"RB ALTMAN, O JARDETZKY",Oxford University Press,,0,1986
A Bayesian framework for combining heterogeneous data sources for gene function,"OG Troyanskaya, K Dolinski, AB Owen, RB Altman, D Botstein",,,0,0
147 An interview with Derek Lowe,"M Berk, GS Malhi, LJ Gray, OM Dean, B Percha, RB Altman, JW Steed, ...",,,0,0
Associate Editor in Chief,"L Cao, A Abbasi, RB Altman, B An, J Caverlee, J Dix, D Doermann, ...",,,0,0
2017 Reviewer Acknowledgment,"C Abdallah, D Abernethy, D Adler, S Agarwal, B Agoram, S Agrawal, ...",,,0,0
2016 Reviewer Acknowledgement,"L Aarons, C Abdallah, H Abdolmaleky, DR Abernethy, M Abou-El-Enein, ...",,,0,0
Corrigendum Bioinformatics challenges for personalized medicine,"GH Fernald, E Capriotti, R Daneshjou, KJ Karczewski, RB Altman",,,0,0
Conserved biochemical features among four protease molecules with no structural or sequential homology.,"RB Altman, SC Bagley","BIOCOMPUTING'96, 701",,0,0
22.1 The Problem of Handling Biological Information,"RB ALTMAN, SD MOONEY",,,0,0
A general framework for dose optimization.,"E Ashley, RB Altman, A Das",,,0,0
Supplementary Material Integrating systems biology sources illuminates drug action,"A Gottlieb, RB Altman",,,0,0
H-STAR Institute Faculty Publications 2008-09,"R Altman, J Bailenson","Media Psychology 12, 195-209",,0,0
"Our thanks to all those who have helped with this issue of Pharmacogenomics. Listed below are authors, referees and others who have kindly given their time, effort and …","A Alfirevic, J Altena, C Ayuso, E Baca-Garcia, DT Bau, M Beaulieu, ...",,,0,0
"Our thanks to all those who have helped with this issue of Pharmacogenomics. Listed below are authors, referees and others who have kindly given their time, effort and …","C Adithan, S Amur, UA Argikar, M Beaulieu, NR Biermasz, D Booth, ...",,,0,0
Reuse with PROTÉGÉ-II: Adapting Problem-Solving Methods with Mapping Relations,"JH Gennari, RB Altman, MA Musen",,,0,0
Industrial Advisory Committee,"RM Bergman, MC Diagnostics, R Altman, E Berbari, TJ Deming, ...",,,0,0
MScanner: A tool to expand a corpus of Medline citations,"GL POULTER, C SEOIGHE, DL RUBIN, RB ALTMAN","Sponsored by the University of the Witwatersrand, Johannesburg Department of …",,0,0
"Advanced Query Mechanisms for Biological Databases, Agarwal, Pankaj, Allison, L., Aloy, Patrick,","RB Altman, A Amir, EA Ananko, WR Atchley, K Atteson, FX Aviles, ...",,,0,0
"Xiaohua Hu, Ion Mandoiu, Zoran Obradovic, BIBM 20007 Program Chairs","R Altman, M Jordan, R Karp",,,0,0
"Reviewers: Volume 8, 2010","W Agger, R Ajjan, K Algazy, RB Altman, SM Ansell, DM Aronoff, ...",Clinical Medicine & Research,,0,0
About the SimTK Engineering Journal,"MA Sherman, RB Altman, SL Delp, JP Schmidt, DS Paik, FC Anderson, ...",,,0,0
Automated Prediction of Phosphorylation Sites: Existing Methods and the Role of Structure,"S Wu, MY So, RB Altman",,,0,0
BIOINFORMATICS CONFERENCE,"L Hood, R Altman, B Palsson, D Gusfield, S Brenner, M Levine",,,0,0
T hi rd In tern a tional Co n feren ce on In tell i gent Sys tems for Molecular Biol o gy,"C Rawlings, D Clark, R Altman, L Hunter, T Lengauer, S Wodak",,,0,0
"Asomaning, K, 613 Avila, PC, 489 Azuma, M, 955 Baas, F, 67 Backman, JT, 447","L Acion, JP Adam, A Adjei, PK Aggarwal, H Agren, N Ahituv, E Aklillu, ...","Gut 1, 505",,0,0
"Our thanks to all those who have helped with this issue of Pharmacogenomics. Listed below are authors, referees and others who have kindly given their time, effort and …","R Abbate, P Abete, T Ali, V Altmann, L Beltrán, L Bendall, M Bernardo, ...",,,0,0
Load Balancing Irregular Hierarchical Parallelism: A Case Study from Biomolecular Structure Computation,"CCCJP Singh, RB Altman",,,0,0
Organizing & Program Committee,"C Rawlings, D Clark, R Altman, L Hunter, T Lengauer, S Wodak, ...",,,0,0
POSTDOCTORAL TRAINING,RB Altman,,,0,0
ANALYSIS FEATURES,"FY Wang, H Chen, J Hendler, RB Altman, R Benjamins, S Coradeschi, ...",,,0,0
Miscellaneous Projects within Helix Group,"R Altman, D Fridsma, R Tombropoulos, J Brinkley",,,0,0
A new disease-specific machine learning approach for the prediction of cancer-related SNPs,"E Capriotti, RB Altman",,,0,0
"CAMPAIGN–Clustering Algorithms in Modular, Parallel, and Accelerated Implementation for GPU Nodes","KJ Kohlhoff, M Sosnick, VS Pande, RB Altman",,,0,0
Supporting Structural Computations ON THE Web: Application TO Ribosomal Modeling,"RO Chen, R Felciano, RB Altman",,,0,0
"HYEOUN-AE PARK, CHARLES MEAD, MARGARETA EHNFORS, HEIMAR F. MARIN","RB ALTMAN, IS KOHANE, KA MCCORMICK, PL MILLER, JG OZBOLT, ...",,,0,0
Current Issue Highlights,"AR Vaccaro, GD Schroeder",,,0,0
REVISED manuscript (CAM 537/94) for J. Mol. Biol.(sent Feb 16,"M Gerstein, RB Altman",,,0,0
"Structure Motifs in a Set of RNA Sequences, 120 Flamm, Christoph, 88 Flores, Tomas P., 241","S Fortier, CF Allex, RB Altman, MA Andrade, R Apweiler, W Arnold, ...",,,0,0
Modeling DSM-IV Criteria in the Autism Ontology,"O Mugzach, M Peleg, SC Bagley, RB Altman",,,0,0
ISMB- Organization,"J Glasgow, T Littlejohn, F Major, R Lathrop, D Sankoff, C Sensen",,,0,0
Using Physicochemical Properties to Identify Protein Functional Sites,"MP Liang, S Wu, RB Altman",,,0,0
Graphical Style Sheets: Mapping Domain Data to Domain Graphics,"RM Felciano, RB Altman",,,0,0
PREDICTING DISEASE-RELATED SINGLE AMINO ACID POLYMORPHISMS USING PROTEIN STRUCTURE,"E Capriotti, RB Altman",,,0,0
247 Erratum,"AW WU, LH LUBOMSKI, M FAHEY, DM STEINWACHS, L ENGINEER, ...",,,0,0
